Search Results for: diet challenge 2013

Low-carbohydrate diet – Wikipedia

Posted: December 7, 2016 at 11:43 am

Low-carbohydrate diets or low-carb diets are dietary programs that restrict carbohydrate consumption, often for the treatment of obesity or diabetes. Foods high in easily digestible carbohydrates (e.g., sugar, bread, pasta) are limited or replaced with foods containing a higher percentage of fats and moderate protein (e.g., meat, poultry, fish, shellfish, eggs, cheese, nuts, and seeds) and other foods low in carbohydrates (e.g., most salad vegetables such as spinach, kale, chard and collards), although other vegetables and fruits (especially berries) are often allowed. The amount of carbohydrate allowed varies with different low-carbohydrate diets.

Such diets are sometimes 'ketogenic' (i.e., they restrict carbohydrate intake sufficiently to cause ketosis). The induction phase of the Atkins diet[1][2][3] is ketogenic.

The term "low-carbohydrate diet" is generally applied to diets that restrict carbohydrates to less than 20% of caloric intake, but can also refer to diets that simply restrict or limit carbohydrates to less than recommended proportions (generally less than 45% of total energy coming from carbohydrates).[4][5]

Low-carbohydrate diets are used to treat or prevent some chronic diseases and conditions, including cardiovascular disease, metabolic syndrome, auto-brewery syndrome, high blood pressure, and diabetes.[6][7]

Gary Taubes has argued that low-carbohydrate diets are closer to the ancestral diet of humans before the origin of agriculture, and humans are genetically adapted to diets low in carbohydrate.[8] Direct archaeological or fossil evidence on nutrition during the Paleolithic, when all humans subsisted by hunting and gathering, is limited, but suggests humans evolved from the vegetarian diets common to other great apes to one with a greater level of meat-eating.[9] Some close relatives of modern Homo sapiens, such as the Neanderthals, appear to have been almost exclusively carnivorous.[10]

A more detailed picture of early human diets before the origin of agriculture may be obtained by analogy to contemporary hunter-gatherers. According to one survey of these societies, a relatively low carbohydrate (2240% of total energy), animal food-centered diet is preferred "whenever and wherever it [is] ecologically possible", and where plant foods do predominate, carbohydrate consumption remains low because wild plants are much lower in carbohydrate and higher in fiber than modern domesticated crops.[11] Primatologist Katherine Milton, however, has argued that the survey data on which this conclusion is based inflate the animal content of typical hunter-gatherer diets; much of it was based on early ethnography, which may have overlooked the role of women in gathering plant foods.[12] She has also highlighted the diversity of both ancestral and contemporary foraging diets, arguing no evidence indicates humans are especially adapted to a single paleolithic diet over and above the vegetarian diets characteristic of the last 30 million years of primate evolution.[13]

The origin of agriculture brought about a rise in carbohydrate levels in human diets.[14] The industrial age has seen a particularly steep rise in refined carbohydrate levels in Western societies, as well as urban societies in Asian countries, such as India, China, and Japan.

In 1797, John Rollo reported on the results of treating two diabetic Army officers with a low-carbohydrate diet and medications. A very low-carbohydrate, ketogenic diet was the standard treatment for diabetes throughout the 19th century.[15][16]

In 1863, William Banting, a formerly obese English undertaker and coffin maker, published "Letter on Corpulence Addressed to the Public", in which he described a diet for weight control giving up bread, butter, milk, sugar, beer, and potatoes.[17] His booklet was widely read, so much so that some people used the term "Banting" for the activity usually called "dieting".[18]

In 1888, James Salisbury introduced the Salisbury steak as part of his high-meat diet, which limited vegetables, fruit, starches, and fats to one-third of the diet.[original research?]

In the early 1900s Frederick Madison Allen developed a highly restrictive short term regime which was described by Walter R. Steiner at the 1916 annual convention of the Connecticut State Medical Society as The Starvation Treatment of Diabetes Mellitus.[19]:176177[20][21][22] People showing very high urine glucose levels were confined to bed and restricted to an unlimited supply of water, coffee, tea, and clear meat broth until their urine was "sugar free"; this took two to four days but sometimes up to eight.[19]:177 After the person's urine was sugar-free food was re-introduced; first only vegetables with less than 5g of carbohydate per day, eventually adding fruits and grains to build up to 3g of carbohydrate per kilogram of body weight. Then eggs and meat were added, building up to 1g of protein/kg of body weight per day, then fat was added to the point where the person stopped losing weight or a maximum of 40 calories of fat per kilogram per day was reached. The process was halted if sugar appeared in the person's urine.[19]:177178 This diet was often administered in a hospital in order to better ensure compliance and safety.[19]:179

In 1958, Richard Mackarness M.D. published Eat Fat and Grow Slim, a low-carbohydrate diet with much of the same advice and based on the same theories as those promulgated by Robert Atkins more than a decade later. Mackarness also challenged the "calorie theory" and referenced primitive diets such as the Inuit as examples of healthy diets with a low-carbohydrate and high-fat composition.

In 1967, Irwin Stillman published The Doctor's Quick Weight Loss Diet. The "Stillman diet" is a high-protein, low-carbohydrate, and low-fat diet. It is regarded as one of the first low-carbohydrate diets to become popular in the United States.[23] Other low-carbohydrate diets in the 1960s included the Air Force diet[24] and the drinking man's diet.[25]Austrian physician Wolfgang Lutz published his book Leben Ohne Brot (Life Without Bread) in 1967.[26] However, it was not well known in the English-speaking world.

In 1972, Robert Atkins published Dr. Atkins Diet Revolution, which advocated the low-carbohydrate diet he had successfully used in treating patients in the 1960s (having developed the diet from a 1963 article published in JAMA).[27] The book met with some success, but, because of research at that time suggesting risk factors associated with excess fat and protein, it was widely criticized by the mainstream medical community as being dangerous and misleading, thereby limiting its appeal at the time.[28] Among other things, critics pointed out that Atkins had done little real research into his theories and based them mostly on his clinical work. Later that decade, Walter Voegtlin and Herman Tarnower published books advocating the Paleolithic diet and Scarsdale diet, respectively, each meeting with moderate success.[29][not in citation given]

The concept of the glycemic index was developed in 1981 by David Jenkins to account for variances in speed of digestion of different types of carbohydrates. This concept classifies foods according to the rapidity of their effect on blood sugar levels with fast-digesting simple carbohydrates causing a sharper increase and slower-digesting complex carbohydrates, such as whole grains, a slower one.[30] The concept has been extended to include the amount of carbohydrate actually absorbed, as well, as a tablespoonful of cooked carrots is less significant overall than a large baked potato (effectively pure starch, which is efficiently absorbed as glucose), despite differences in glycemic indices.

In the 1990s, Atkins published an update from his 1972 book, Dr. Atkins New Diet Revolution, and other doctors began to publish books based on the same principles. This has been said to be the beginning of what the mass media call the "low carb craze" in the United States.[31] During the late 1990s and early 2000s, low-carbohydrate diets became some of the most popular diets in the US. By some accounts, up to 18% of the population was using one type of low-carbohydrate diet or another at the peak of their popularity,[32] and this use spread to many countries.[citation needed]Food manufacturers and restaurant chains like Krispy Kreme noted the trend, as it affected their businesses.[33] Parts of the mainstream medical community has denounced low-carbohydrate diets as being dangerous to health, such as the AHA in 2001,[34] the American Kidney Fund in 2002,[35] Low-carbohydrate advocates did some adjustments of their own, increasingly advocating controlling fat and eliminating trans fat.[36][37]

Proponents who appeared with new diet guides at that time like the Zone diet intentionally distanced themselves from Atkins and the term 'low carb' because of the controversies, though their recommendations were based on largely the same principles .[38][39] It can be controversial which diets are low-carbohydrate and which are not.[citation needed] The 1990s and 2000s saw the publication of an increased number of clinical studies regarding the effectiveness and safety (pro and con) of low-carbohydrate diets (see low-carbohydrate diet medical research).

In the United States, the diet has continued to garner attention in the medical and nutritional science communities, and also inspired a number of hybrid diets that include traditional calorie-counting and exercise regimens.[7][40][41][42] Other low-carb diets, such as the Paleo Diet, focus on the removal of certain foods from the diet, such as sugar and grain.[43] On September 2, 2014 a small randomized trial by the NIH of 148 men and women comparing a low-carbohydrate diet with a low fat diet without calorie restrictions over one year showed that participants in the low-carbohydrate diet had greater weight loss than those on the low-fat diet.[44] The low-fat group lost weight, but appeared to lose more muscle than fat.[45]

No consensus definition exists of what precisely constitutes a low-carbohydrate diet.[46] Medical researchers and diet advocates may define different levels of carbohydrate intake when specifying low-carbohydrate diets.[46][not in citation given]

The American Academy of Family Physicians defines low-carbohydrate diets as diets that restrict carbohydrate intake to 20 to 60 grams per day, typically less than 20% of caloric intake.[47]

The body of research underpinning low-carbohydrate diets has grown significantly in the decades of the 1990s and 2000s.[48][49] Most research centers on the relationship between carbohydrate intake and blood sugar levels (i.e., blood glucose), as well as the two primary hormones produced in the pancreas, that regulate the blood sugar level, insulin, which lowers it, and glucagon, which raises it.[50]

Low-carbohydrate diets in general recommend reducing nutritive carbohydrates, commonly referred to as "net carbs", i.e., grams of total carbohydrates reduced by the non-nutritive carbohydrates[51][52] to very low levels. This means sharply reducing consumption of desserts, breads, pastas, potatoes, rice, and other sweet or starchy foods. Some recommend levels less than 20g of "net carbs" per day, at least in the early stages of dieting[53] (for comparison, a single slice of white bread typically contains 15g of carbohydrate, almost entirely starch). By contrast, the U.S. Institute of Medicine recommends a minimum intake of 130g of carbohydrate per day.[54] The FAO and WHO similarly recommend that the majority of dietary energy come from carbohydrates.[55][56]

Although low-carbohydrate diets are most commonly discussed as a weight-loss approach, some experts have proposed using low-carbohydrate diets to mitigate or prevent diseases, including diabetes, metabolic disease, and epilepsy.[57][58] Some low-carbohydrate proponents and others argue that the rise in carbohydrate consumption, especially refined carbohydrates, caused the epidemic levels of many diseases in modern society, including metabolic disease and type 2 diabetes.[59][60][61][62]

A category of diets is known as low-glycemic-index diets (low-GI diets) or low-glycemic-load diets (low-GL diets), in particular the Low GI Diet.[63] In reality, low-carbohydrate diets can also be low-GL diets (and vice versa) depending on the carbohydrates in a particular diet. In practice, though, "low-GI"/"low-GL" diets differ from "low-carb" diets in the following ways: First, low-carbohydrate diets treat all nutritive carbohydrates as having the same effect on metabolism, and generally assume their effect is predictable. Low-GI/low-GL diets are based on the measured change in blood glucose levels in various carbohydrates these vary markedly in laboratory studies. The differences are due to poorly understood digestive differences between foods. However, as foods influence digestion in complex ways (e.g., both protein and fat delay absorption of glucose from carbohydrates eaten at the same time) it is difficult to even approximate the glycemic effect (e.g., over time or even in total in some cases) of a particular meal.[64]

The low-insulin-index diet, is similar, except it is based on measurements of direct insulemic responses i.e., the amount of insulin in the bloodstream to food rather than glycemic response the amount of glucose in the bloodstream. Although such diet recommendations mostly involve lowering nutritive carbohydrates, some low-carbohydrate foods are discouraged, as well (e.g., beef).[65] Insulin secretion is stimulated (though less strongly) by other dietary intake. Like glycemic-index diets, predicting the insulin secretion from any particular meal is difficult, due to assorted digestive interactions and so differing effects on insulin release.[citation needed]

At the heart of the debate about most low-carbohydrate diets are fundamental questions about what is a 'normal' diet and how the human body is supposed to operate. These questions can be outlined as follows.

The diets of most people in modern Western nations, especially the United States, contain large amounts of starches, including refined flours, and substantial amounts of sugars, including fructose. Most Westerners seldom exhaust stored glycogen supplies and rarely go into ketosis. This has been regarded by the majority of the medical community in the last century as normal for humans.[citation needed] Ketosis should not be confused with ketoacidosis, a dangerous and extreme ketotic condition associated with type I diabetes. Some in the medical community have regarded ketosis as harmful and potentially life-threatening, believing it unnecessarily stresses the liver and causes destruction of muscle tissues.[citation needed] A perception developed that getting energy chiefly from dietary protein rather than carbohydrates causes liver damage and that getting energy chiefly from dietary fats rather than carbohydrates causes heart disease and other health problems. This view is still held by the majority of those in the medical and nutritional science communities.[66][67][68] However, it is now widely recognized that periodic ketosis is normal, and that ketosis provides a number of benefits, including neuroprotection against diverse types of cellular injury.[69]

People critical of low-carbohydrate diets cite hypoglycemia and ketoacidosis as risk factors. While mild acidosis may be a side effect when beginning a ketogenic diet,[70][71] no known health emergencies have been recorded. It should not be conflated with diabetic ketoacidosis, which can be life-threatening.

A diet very low in starches and sugars induces several adaptive responses. Low blood glucose causes the pancreas to produce glucagon,[72] which stimulates the liver to convert stored glycogen into glucose and release it into the blood. When liver glycogen stores are exhausted, the body starts using fatty acids instead of glucose. The brain cannot use fatty acids for energy, and instead uses ketones produced from fatty acids by the liver. By using fatty acids and ketones as energy sources, supplemented by conversion of proteins to glucose (gluconeogenesis), the body can maintain normal levels of blood glucose without dietary carbohydrates.

Most advocates of low-carbohydrate diets, such as the Atkins diet, argue that the human body is adapted to function primarily in ketosis.[73][74] They argue that high insulin levels can cause many health problems, most significantly fat storage and weight gain. They argue that the purported dangers of ketosis are unsubstantiated (some of the arguments against ketosis result from confusion between ketosis and ketoacidosis, which is a mostly diabetic condition unrelated to dieting or low-carbohydrate intake).[75] They also argue that fat in the diet only contributes to heart disease in the presence of high insulin levels and that if the diet is instead adjusted to induce ketosis, fat and cholesterol in the diet are beneficial. Most low-carb diet plans discourage consumption of trans fat.

On a high-carbohydrate diet, glucose is used by cells in the body for the energy needed for their basic functions, and about two-thirds of body cells require insulin to use glucose. Excessive amounts of blood glucose are thought to be a primary cause of the complications of diabetes, when glucose reacts with body proteins (resulting in glycosolated proteins) and change their behavior. Perhaps for this reason, the amount of glucose tightly maintained in the blood is quite low. Unless a meal is very low in starches and sugars, blood glucose will rise for a period of an hour or two after a meal. When this occurs, beta cells in the pancreas release insulin to cause uptake of glucose into cells. In liver and muscle cells, more glucose is taken in than is needed and stored as glycogen (once called 'animal starch').[76] Diets with a high starch/sugar content, therefore, cause release of more insulin, and so more cell absorption. In diabetics, glucose levels vary in time with meals and vary a little more as a result of high-carbohydrate meals. In nondiabetics, blood-sugar levels are restored to normal levels within an hour or two, regardless of the content of a meal.

However, the ability of the body to store glycogen is finite. Once liver and muscular stores are full to the maximum, adipose tissue (subcutaneous and visceral fat stores) becomes the site of sugar storage in the form of fat.[citation needed] The body's ability to store fat is almost limitless, hence the modern dilemma of morbid obesity.

While any diet devoid of essential fatty acids (EFAs) and essential amino acids (EAAs) will result in eventual death, a diet completely without carbohydrates can be maintained indefinitely because triglycerides (which make up fat stored in the body and dietary fat) include a (glycerol) molecule which the body can easily convert to glucose.[77] It should be noted that the EFAs and all amino acids are structural building blocks, not inherent fuel for energy. However, a very-low-carbohydrate diet (less than 20 g per day) may negatively affect certain biomarkers[78] and produce detrimental effects in certain types of individuals (for instance, those with kidney problems). The opposite is also true; for instance, clinical experience suggests very-low-carbohydrate diets for patients with metabolic syndrome.[79]

Because of the substantial controversy regarding low-carbohydrate diets and even disagreements in interpreting the results of specific studies, it is difficult to objectively summarize the research in a way that reflects scientific consensus.[80] Although some research has been done throughout the 20th century,[81] most directly relevant scientific studies have occurred in the 1990s and early 2000s. Researchers and other experts have published articles and studies that run the gamut from promoting the safety and efficacy of these diets[82][83] to questioning their long-term validity[84][85] to outright condemning them as dangerous.[86][87] A significant criticism of the diet trend was that no studies evaluated the effects of the diets beyond a few months. However, studies emerged which evaluate these diets over much longer periods, controlled studies as long as two years and survey studies as long as two decades.[82][88][89][90][91]

A systematic review published in 2014 included 19 trials with a total of 3,209 overweight and obese participants, some with diabetes. The review included both extreme low carbohydrate diets high in both protein and fat, as well as less extreme low carbohydrate diets that are high in protein but with recommended intakes of fat. The authors found that when the amount of energy (kilojoules/calories) consumed by people following the low carbohydrate and balanced diets (45 to 65% of total energy from carbohydrates, 25 to 35% from fat, and 10 to 20% from protein) was similar, there was no difference in weight loss after 3 to 6 months and after 1 to 2 years in those with and without diabetes. For blood pressure, cholesterol levels and diabetes markers there was also no difference detected between the low carbohydrate and the balanced diets. The follow-up of these trials was no longer than two years, which is too short to provide an adequate picture of the long term risk of following a low carbohydrate diet.[5]

A 2003 meta-analysis that included randomized controlled trials found that "low-carbohydrate, non-energy-restricted diets appear to be at least as effective as low-fat, energy-restricted diets in inducing weight loss for up to one year."[92][93][94] A 2007 JAMA study comparing the effectiveness of the Atkins low-carb diet to several other popular diets concluded, "In this study, premenopausal overweight and obese women assigned to follow the Atkins diet, which had the lowest carbohydrate intake, lost more weight and experienced more favorable overall metabolic effects at 12 months than women assigned to follow the Zone, Ornish, or LEARN diets."[89] A July 2009 study of existing dietary habits associated a low-carbohydrate diet with obesity, although the study drew no explicit conclusion regarding the cause: whether the diet resulted in the obesity or the obesity motivated people to adopt the diet.[95] A 2013 meta-analysis that included only randomized controlled trials with one year or more of follow-up found, "Individuals assigned to a very low carbohydrate ketogenic diet achieve a greater weight loss than those assigned to a low fat diet in the long term."[96] In 2013, after reviewing 16,000 studies, Sweden's Council on Health Technology Assessment concluded low-carbohydrate diets are more effective as a means to reduce weight than low-fat diets, over a short period of time (six months or less). However, the agency also concluded, over a longer span (1224 months), no differences occur in effects on weight between strict or moderate low-carb diets, low-fat diets, diets high in protein, Mediterranean diet, or diets aiming at low glycemic indices.[97]

In one theory, one of the reasons people lose weight on low-carbohydrate diets is related to the phenomenon of spontaneous reduction in food intake.[98]

Carbohydrate restriction may help prevent obesity and type 2 diabetes,[99][100] as well as atherosclerosis.[101]

Potential favorable changes in triglyceride and high-density lipoprotein cholesterol values should be weighed against potential unfavorable changes in low-density lipoprotein cholesterol and total cholesterol values when low-carbohydrate diets to induce weight loss are considered.[102] However, the type of LDL cholesterol should also be taken into account here, as it could be that small, dense LDL is decreased and larger LDL molecules are increased with low-carb diets.[citation needed] The health effects of the different molecules are still being elucidated, and many cholesterol tests do not account for such details, but small, dense LDL is thought to be problematic and large LDL is not. A 2008 systematic review of randomized controlled studies that compared low-carbohydrate diets to low-fat/low-calorie diets found the measurements of weight, HDL cholesterol, triglyceride levels, and systolic blood pressure were significantly better in groups that followed low-carbohydrate diets. The authors of this review also found a higher rate of attrition in groups with low-fat diets, and concluded, "evidence from this systematic review demonstrates that low-carbohydrate/high-protein diets are more effective at six months and are as effective, if not more, as low-fat diets in reducing weight and cardiovascular disease risk up to one year", but they also called for more long-term studies.[103]

A study of more than 100,000 people over more than 20 years within the Nurses' Health Study observationally concluded a low-carbohydrate diet high in vegetables, with a large proportion of proteins and oils coming from plant sources, decreases mortality with a hazard ratio of 0.8.[104] In contrast, a low-carbohydrate diet with largely animal sources of protein and fat increases mortality, with a hazard ratio of 1.1.[104] This study, however, has been met with criticism, due to the unreliability of the self-administered food frequency questionnaire, as compared to food journaling,[105] as well as classifying "low-carbohydrate" diets based on comparisons to the group as a whole (decile method) rather than surveying dieters following established low-carb dietary guidelines like the Atkins or Paleo diets.[106]

Opinions regarding low-carbohydrate diets vary throughout the medical and nutritional science communities, yet government bodies, and medical and nutritional associations, have generally opposed this nutritional regimen.[citation needed] Since 2003, some organizations have gradually begun to relax their opposition to the point of cautious support for low-carbohydrate diets. Some of these organizations receive funding from the food industry.[citation needed] Official statements from some organizations:

The AAFP released a 'discussion paper' on the Atkins diet in 2006. The paper expresses reservations about the Atkins plan, but acknowledges it as a legitimate weight-loss approach.[107]

The ADA revised its Nutrition Recommendations and Interventions for Diabetes in 2008 to acknowledge low-carbohydrate diets as a legitimate weight-loss plan.[108][109] The recommendations fall short of endorsing low-carbohydrate diets as a long-term health plan, and do not give any preference to these diets. Nevertheless, this is perhaps the first statement of support, albeit for the short term, by a medical organization.[110][111] In its 2009 publication of Clinical Practice Recommendations, the ADA again reaffirmed its acceptance of carbohydrate-controlled diets as an effective treatment for short-term (up to one year) weight loss among obese people suffering from type two diabetes.[112]

As of 2003 in commenting on a study in the Journal of the American Medical Association, a spokesperson for the American Dietetic Association reiterated the association's belief that "there is no magic bullet to safe and healthful weight loss."[113] The Association specifically endorses the high-carbohydrate diet recommended by the National Academy of Sciences. They have stated "Calories cause weight gain. Excess calories from carbohydrates are not any more fattening than calories from other sources. Despite the claims of low-carb diets, a high-carbohydrate diet does not promote fat storage by enhancing insulin resistance."[114][bettersourceneeded]

As of 2008[update] the AHA states categorically that it "doesn't recommend high-protein diets."[115] A science advisory from the association further states the association's belief that these diets "may be associated with increased risk for coronary heart disease."[34] The AHA has been one of the most adamant opponents of low-carbohydrate diets.[citation needed] Dr. Robert Eckel, past president, noted that a low-carbohydrate diet could potentially meet AHA guidelines if it conformed to the AHA guidelines for low fat content.[116]

The position statement by the Heart Foundation regarding low-carbohydrate diets states, "the Heart Foundation does not support the adoption of VLCARB diets for weight loss."[46] Although the statement recommends against use of low-carbohydrate diets, it explains their major concern is saturated fats as opposed to carbohydrate restriction and protein. Moreover, other statements suggest their position might be re-evaluated in the event of more evidence from longer-term studies.

The consumer advice statements of the NHS regarding low-carbohydrate diets state that "eating a high-fat diet could increase your risk of heart disease" and "try to ensure starchy foods make up about a third of your diet"[117]

In 2008, the Socialstyrelsen in Sweden altered its standing regarding low-carbohydrate diets.[118] Although formal endorsement of this regimen has not yet appeared, the government has given its formal approval for using carbohydrate-controlled diets for medically supervised weight loss.

In a recommendation for diets suitable for diabetes patients published in 2011 a moderate low-carb option (3040%) is suggested.[119]

The HHS issues consumer guidelines for maintaining heart health which state regarding low-carbohydrate diets that "they're not the route to healthy, long-term weight management."[120]

Low-carbohydrate diets became a major weight loss and health maintenance trend during the late 1990s and early 2000s.[121][122][123] While their popularity has waned recently from its peak, they remain popular.[124][125] This diet trend has stirred major controversies in the medical and nutritional sciences communities and, as yet, there is not a general consensus on their efficacy or safety.[126][127] Many in the medical community remain generally opposed to these diets for long term health[128] although there has been a recent softening of this opposition by some organizations.[129][130]

Because of the substantial controversy regarding low-carbohydrate diets, and even disagreements in interpreting the results of specific studies, it is difficult to objectively summarize the research in a way that reflects scientific consensus.[131][132][133]

Although there has been some research done throughout the twentieth century, most directly relevant scientific studies have occurred in the 1990s and early 2000s and, as such, are relatively new and the results are still debated in the medical community.[132] Supporters and opponents of low-carbohydrate diets frequently cite many articles (sometimes the same articles) as supporting their positions.[134][135][136] One of the fundamental criticisms of those who advocate the low-carbohydrate diets has been the lack of long-term studies evaluating their health risks.[137][138] This has begun to change as longer term studies are emerging.[82]

A 2012 systematic review studying the effects of low-carbohydrate diet on weight loss and cardiovascular risk factors showed the LCD to be associated with significant decreases in body weight, body mass index, abdominal circumference, blood pressure, triglycerides, fasting blood sugar, blood insulin and plasma C-reactive protein, as well as an increase in high-density lipoprotein cholesterol (HDL). Low-density lipoprotein cholesterol (LDL) and creatinine did not change significantly. The study found the LCD was shown to have favorable effects on body weight and major cardiovascular risk factors (but concluded the effects on long-term health are unknown). The study did not compare health benefits of LCD to low-fat diets.[139]

A meta-analysis published in the American Journal of Clinical Nutrition in 2013 compared low-carbohydrate, Mediterranean, vegan, vegetarian, low-glycemic index, high-fiber, and high-protein diets with control diets. The researchers concluded that low-carbohydrate, Mediterranean, low-glycemic index, and high-protein diets are effective in improving markers of risk for cardiovascular disease and diabetes.[140]

In the first week or two of a low-carbohydrate diet, much of the weight loss comes from eliminating water retained in the body.[141] The presence of insulin in the blood fosters the formation of glycogen stores in the body, and glycogen is bound with water, which is released when insulin and blood sugar drop.[citation needed][142] A ketogenic diet is known to cause dehydration as an early, temporary side-effect.[143]

Advocates of low-carbohydrate diets generally dispute any suggestion that such diets cause weakness or exhaustion (except in the first few weeks as the body adjusts), and indeed most highly recommend exercise as part of a healthy lifestyle.[142][144] A large body of evidence stretching back to the 1880s shows that physical performance is not negatively affected by ketogenic diets once a person has been accustomed to such a diet.[145]

Arctic cultures, such as the Inuit, were found to lead physically demanding lives consuming a diet of about 1520% of their calories from carbohydrates, largely in the form of glycogen from the raw meat they consumed.[145][146][147][148] However, studies also indicate that while low-carb diets will not reduce endurance performance after adapting, they will probably deteriorate anaerobic performance such as strength-training or sprint-running because these processes rely on glycogen for fuel.[144]

Many critics argue that low-carbohydrate diets inherently require minimizing vegetable and fruit consumption, which in turn robs the body of important nutrients.[149] Some critics imply or explicitly argue that vegetables and fruits are inherently all heavily concentrated sources of carbohydrates (so much so that some sources treat the words 'vegetable' and 'carbohydrate' as synonymous).[150] While some fruits may contain relatively high concentrations of sugar, most are largely water and not particularly calorie-dense. Thus, in absolute terms, even sweet fruits and berries do not represent a significant source of carbohydrates in their natural form, and also typically contain a good deal of fiber which attenuates the absorption of sugar in the gut.[151] Lastly, most of the sugar in fruit is fructose, which has a reported negligible effect on insulin levels in obese subjects.[152]

Most vegetables are low- or moderate-carbohydrate foods (in the context of these diets, fiber is excluded because it is not a nutritive carbohydrate). Some vegetables, such as potatoes and carrots, have high concentrations of starch, as do corn and rice. Most low-carbohydrate diet plans accommodate vegetables such as broccoli, spinach, cauliflower, and peppers.[153] The Atkins diet recommends that most dietary carbs come from vegetables. Nevertheless, debate remains as to whether restricting even just high-carbohydrate fruits, vegetables, and grains is truly healthy.[154]

Contrary to the recommendations of most low-carbohydrate diet guides, some individuals may choose to avoid vegetables altogether to minimize carbohydrate intake. Low-carbohydrate vegetarianism is also practiced.

Raw fruits and vegetables are packed with an array of other protective chemicals, such as vitamins, flavonoids, and sugar alcohols. Some of those molecules help safeguard against the over-absorption of sugars in the human digestive system.[155][156] Industrial food raffination depletes some of those beneficial molecules to various degrees, including almost total removal in many cases.[157]

The major low-carbohydrate diet guides generally recommend multivitamin and mineral supplements as part of the diet regimen, which may lead some to believe these diets are nutritionally deficient. The primary reason for this recommendation is that if the switch from a high-carbohydrate to a low-carbohydrate, ketogenic diet is rapid, the body can temporarily go through a period of adjustment during which it may require extra vitamins and minerals. This is because the body releases excess fluids stored during high-carbohydrate eating. In other words, the body goes through a temporary "shock" if the diet is changed to low-carbohydrate quickly, just as it would changing to a high-carbohydrate diet quickly. This does not, in and of itself, indicate that either type of diet is nutritionally deficient. While many foods rich in carbohydrates are also rich in vitamins and minerals, many low-carbohydrate foods are similarly rich in vitamins and minerals.[158]

A common argument in favor of high-carbohydrate diets is that most carbohydrates break down readily into glucose in the bloodstream, and therefore the body does not have to work as hard to get its energy in a high-carbohydrate diet as a low-carbohydrate diet. This argument, by itself, is incomplete. Although many dietary carbohydrates do break down into glucose, most of that glucose does not remain in the bloodstream for long. Its presence stimulates the beta cells in the pancreas to release insulin, which has the effect of causing about two-thirds of body cells to take in glucose, and causing fat cells to take in fatty acids and store them. As the blood-glucose level falls, the amount of insulin released is reduced; the entire process is completed in non-diabetics in an hour or two after eating.[citation needed] High-carbohydrate diets require more insulin production and release than low-carbohydrate diets,[citation needed] and some evidence indicates the increasingly large percentage of calories consumed as refined carbohydrates is positively correlated with the increased incidence of metabolic disorders such as type 2 diabetes.[159]

In addition, this claim neglects the nature of the carbohydrates ingested. Some are indigestible in humans (e.g., cellulose), some are poorly digested in humans (e.g., the amylose starch variant), and some require considerable processing to be converted to absorbable forms. In general, uncooked or unprocessed (e.g., milling, crushing, etc.) foods are harder (typically much harder) to absorb, so do not raise glucose levels as much as might be expected from the proportion of carbohydrate present. Cooking (especially moist cooking above the temperature necessary to expand starch granules) and mechanical processing both considerably raise the amount of absorbable carbohydrate and reduce the digestive effort required.

Analyses which neglect these factors are misleading and will not result in a working diet, or at least one which works as intended. In fact, some evidence indicates the human brain the largest consumer of glucose in the body can operate more efficiently on ketones (as efficiency of source of energy per unit oxygen).[160]

The restriction of starchy plants, by definition, severely limits the dietary intake of microbiota accessible carbohydrates (MACs) and may negatively affect the microbiome in ways that contribute to disease.[161] Starchy plants, in particular, are a main source of resistant starch an important dietary fiber with strong prebiotic properties.[162][163][164] Resistant starches are not digestible by mammals and are fermented and metabolized by gut flora into short chain fatty acids, which are well known to offer a wide range of health benefits.[163][165][166][167][168][169] Resistant starch consumption has been shown to improve intestinal/colonic health, blood sugar, glucose tolerance, insulin-sensitivity and satiety.[170][171][172] Public health authorities and food organizations such as the Food and Agricultural Organization, the World Health Organization,[173] the British Nutrition Foundation[174] and the U.S. National Academy of Sciences[175] recognize resistant starch as a beneficial carbohydrate. The Joint Food and Agricultural Organization of the United Nations/World Health Organization Expert Consultation on Human Nutrition stated, "One of the major developments in our understanding of the importance of carbohydrates for health in the past twenty years has been the discovery of resistant starch."[173]

In 2004, the Canadian government ruled that foods sold in Canada could not be marketed with reduced or eliminated carbohydrate content as a selling point, because reduced carbohydrate content was not determined to be a health benefit. The government ruled that existing "low carb" and "no carb" packaging would have to be phased out by 2006.[176]

Some variants of low-carbohydrate diets involve substantially lowered intake of dietary fiber, which can result in constipation if not supplemented.[citation needed] For example, this has been a criticism of the induction phase of the Atkins diet (the Atkins diet is now clearer about recommending a fiber supplement during induction). Most advocates[who?][dubious discuss] today argue that fiber is a "good" carbohydrate and encourage a high-fiber diet.[citation needed]

See the original post here:
Low-carbohydrate diet - Wikipedia

Posted in Diet And Food | Comments Off on Low-carbohydrate diet – Wikipedia

My 6 month weight loss challenge Fat to Fit. My X-Fat Program Day 26 – Video

Posted: March 5, 2013 at 12:43 am


My 6 month weight loss challenge Fat to Fit. My X-Fat Program Day 26
My 6 month weight loss challenge Fat to Fit. My X-Fat Program Day 26 Today I want to talk about water... drink lots of water. I also wanted to share my new find from the supermarket. Carbonated sparkling natural mineral water. I love the stuff. Its got no calories, its got no dangerous chemicals like diet sodas do and its fizzy like your favorite soft drink... Its normally cheaper than soft drinks as well, so give it a go and see if you love it as much as I do.

By: XFat2013

See the rest here:
My 6 month weight loss challenge Fat to Fit. My X-Fat Program Day 26 - Video

Posted in Lose Weight Fast | Comments Off on My 6 month weight loss challenge Fat to Fit. My X-Fat Program Day 26 – Video

Introducing the George Foreman® Grills Weight Loss Challenge and Announcing Spokesperson and Food Network Personality …

Posted: February 6, 2013 at 5:44 pm

MADISON, Wis., Feb. 6, 2013 /PRNewswire/ --George Foreman Grills, the #1 brand in electric grills, has partnered with Gina Neely, Food Network chef, cookbook author and personality of "Down Home with the Neelys" to launch the "George Foreman Grills Weight Loss Challenge" the brand's first ever weight loss program. Brand spokesperson Gina Neely recently took the challenge and lost 20lbs and 12 inches in just 12 weeks. Whether aiming to lose five pounds or fifty, the free 12-week program can help anyone achieve their weight loss goals.

(Photo: http://photos.prnewswire.com/prnh/20130206/NY54069)

"Prior to taking the George Foreman Grills Weight Loss Challenge, I wasn't in my best shape because, like many women, I was busy concentrating on career and family. Even as a chef, I found it hard to make time to eat right and live a balanced life," said Gina Neely. "The George Foreman Grills Weight Loss Challenge is easy to follow because it provides a variety of balanced and nutritious, tasty meals. Now I feel great and look great, and anyone can take the challenge, change their lifestyle and get fabulous results like I did."

The George Foreman Grills Weight Loss Challenge is a safe weight-loss approach that was developed by the brand with Registered Dietitian and Certified Personal Trainer, Sarah Berndt. Sarah is an expert in building everyday weight loss plans as co-owner of Hybrid Fitness and Fit Fresh Cuisine in Madison, Wisconsin. The all-inclusive George Foreman Grills Weight Loss program provides balanced meals and snacks including mouth-watering recipes that were developed for the George Foreman Grill. It also includes strength and cardio workouts as well as a calorie calculator, grocery shopping cheat sheet, food tracker, and restaurant guide. In addition to the meal plans, Gina Neely shares her 500 calories or less recipes created especially for the grill including Southern BBQ Turkey Sliders and Mango-Peach Lettuce Wraps. In addition, consumers can access her tips for weight loss success and enter to win $2,500 by signing up at http://www.georgeforemancooking.com/Challenge.aspx.

"With obesity on the rise for nearly all adult Americans, George Foreman Grills is thrilled to launch this weight loss challenge designed to knock out the fat by creating nutritious and tasty meals made on the grill. The user-friendly plan will help consumers to make a simple change in their diet to lead and maintain a more balanced lifestyle," said Andy Van Wie, Vice President, North America Home Appliances Sales & Marketing, Spectrum Brands. "We are thrilled that Gina Neely has completed her 12-week weight loss journey and will be working on behalf of George Foreman Grills to help others achieve their weight loss goals."

Participants can sign up for the challenge at http://www.georgeforemancooking.com/Challenge.aspx starting January 31st until March 3rd for the next 12-week challenge starting on March 4th. To enter and receive the weight loss kit, contestants must submit their email address and accept the rules. To best track weight loss, it is suggested that contestants submit their before weight, photo and weight loss goal. After completing the 12-week plan, users can enter total pounds lost and a short essay on the experience for a chance to win $2,500 payable by check and a $500 credit for product from Whole Health; a runner up will receive $1,000 and a $500 credit for product from Whole Health.

For complete details, official rules and to complete an entry form, visit http://www.georgeforemancooking.com/Challenge.aspx. The George Foreman Grills Weight Loss Challenge is open to residents of the US, DC and Canada (excluding residents of the province of Quebec) 18 years, or age of majority in state or province of residence, or older. Use of a George Foreman Grill is required. Void where prohibited or restricted by law.

Find George Foreman Grills on Facebook and visit http://www.georgeforemancooking.com/Challenge.aspx for more information, tips, recipes and promotions.

About George ForemanGeorge Foreman is a global leader and manufacturer of electric grills. Committed to developing innovative products that provide great-tasting food, George Foreman strives to make foods faster and more convenient and is a subsidiary of Spectrum Brands Holdings. For more information about George Foreman, visit http://www.georgeforemancooking.com or become a fan of George Foreman Cooking on Facebook.

About Spectrum Brands Holdings, Inc.Spectrum Brands Holdings, a member of the Russell 2000 Index, is a global and diversified consumer products company and a leading supplier of consumer batteries, residential locksets, residential builders' hardware, faucets, shaving and grooming products, personal care products, small household appliances, specialty pet supplies, lawn and garden and home pest control products, and personal insect repellents. Helping to meet the needs of consumers worldwide, our Company offers a broad portfolio of market-leading, well-known and widely trusted brands including Rayovac, Kwikset, Weiser, Baldwin, National Hardware, Pfister, Remington, VARTA, George Foreman, Black & Decker, Toastmaster, Farberware, Tetra, Marineland, Nature's Miracle, Dingo, 8-in-1, FURminator, Littermaid, Spectracide, Cutter, Repel, Hot Shot and Black Flag. Spectrum Brands' products are sold by the world's top 25 retailers and are available in more than one million stores in approximately 140 countries. Spectrum Brands Holdings generated net sales of approximately $3.25 billion in fiscal 2012. On a pro forma basis following the Company's December 2012 acquisition of the Hardware & Home Improvement Group (HHI) from Stanley Black & Decker, Spectrum Brands had net sales of more than $4 billion for fiscal 2012. For more information, visit http://www.spectrumbrands.com.

View post:
Introducing the George Foreman® Grills Weight Loss Challenge and Announcing Spokesperson and Food Network Personality ...

Posted in Lose Weight Fast | Comments Off on Introducing the George Foreman® Grills Weight Loss Challenge and Announcing Spokesperson and Food Network Personality …

Ground-breaking Research Reveals Government Must Focus on Healthy Children's Diets to Prevent Diabetes

Posted: June 15, 2012 at 1:13 am

PLYMOUTH, England, June 14, 2012 /PRNewswire/ --

June 15th 2012 represents a ground-breaking date in the history of diabetes research. After twelve years the EarlyBird project has made significant advances in understanding what triggers diabetes and cardio-vascular disease and the means to determine how advanced these conditions are. The Earlybird research has worryingly shown just how early in life the underlying symptoms of diabetes start, and how focus must move to early prevention through diet not simply physical activity, despite the current focus of government policy.

The EarlyBirds, a randomly selected group of 300 healthy children, have undergone an intensive series of measurements and tests from the age of five to seventeen. Since 2000, the Professor of Endocrinology and Metabolism at the Peninsula Medical School in Plymouth, Terence Wilkin has been leading the 'EarlyBird study' to find which factors in childhood cause diabetes in later life.

The project aim is to help parents, teachers and decision makers in government to understand the preventable factors in childhood that are responsible for the current epidemics of diabetes and heart disease. This radical medical research will provide evidence to help academics identify the causes of diabetes.

The EarlyBird study has been distinctive in combining objective measures of physical activity and body composition, with annual fasting blood samples. These measures reach beyond simple body composition (BMI and body fat) to metabolic health (glucose control, insulin sensitivity, blood fats, cholesterol, blood pressure).

Critical to the success of the programme has been the funding of Dr Chai Patel, his Bright Future Trust and the Patel family who will have donated over 1million by the time the study is completed September 2013.

Dr Chai Patel, said:

"EarlyBird has developed and harnessed critical new advances in medical science in order to challenge some of the misconceptions surrounding diabetes, and its causes, and will undoubtedly lead to better medical practices being implemented to tackle the root cause of diabetes-onset.

"We are all incredibly grateful to the volunteers who have shown commitment, motivation and maturity which has been truly remarkable and would daunt most adults.

"I am proud to have been associated with a project that has massive potential to change lives across the world."

Continued here:
Ground-breaking Research Reveals Government Must Focus on Healthy Children's Diets to Prevent Diabetes

Posted in Diet And Food | Comments Off on Ground-breaking Research Reveals Government Must Focus on Healthy Children's Diets to Prevent Diabetes

Professional Eaters Devour Giant Pizzas, Then Go on Diet

Posted: March 7, 2012 at 10:54 pm

NEW YORK, NY--(Marketwire -03/07/12)- Today DietBet.com, an online social dieting game that gives players the opportunity to compete to lose weight, announced several members of All Pro Eating will pull a dietary 180 and participate in a dietbet. This out-of-ordinary weight-loss challenge kicks-off with a "last supper" competitive eating contest of gigantic New York style pizza slices followed immediately by a weigh-in at the perfect location for such an event, Ripley's Believe It or Not! Times Square Odditorium, located at 234 West 42nd Street, on Friday, March 9 at 11:30 am.

The public is invited to cheer on the eaters as they bulk up before embarking on their four-week weight loss competition. Hopefully the competitors -- and the scales -- can handle getting a little cheese grease and tomato sauce on them from the 32" Koronet pizzas. The eating contest will be immediately followed by the official weigh-in to kick off the dietbet.

Players who reach their goal of dropping four percent of their starting weight in four weeks will split a $1,000 pot. Trained to do nothing but consume everything in front of them as quickly as possible, these men-turned-eating-machines will think twice before competing over the next month in wing-offs, hot dog races, taco triathlons, and milkshake marathons.

Members of All Pro Eating participating in the competition include:

The Champ, The Cannon, and Sisco-Kid will be competing live at Ripley's Odditorium on 42nd Street, while the others will be weighing in remotely. Ripley's Believe It or Not! Times Square's own Greg Dubin, known as the "Great Dubini," will emcee the fattening festivities.

"Competitive eaters going on diets, giant slices of pizza -- you know we're excited to host DietBet's event," said Michael Hirsch, president/general manager of Ripley's Believe It or Not! Times Square. "At Ripley's, we celebrate the unexpected and can't wait to watch this group of pro-eaters in their last meal before starting such an unbelievable feat."

DietBet injects fun, competition, and social collaboration into Americans' seemingly never-ending quest to shed extra weight. Players use the DietBet message boards to offer both encouragement and trash talk. Getting into the spirit, Will "The Champ" Millender recently shipped a case of Twinkies to Todd "The Hungry Genius" Greenwald.

"I've been in all kinds of eating competitions and this is one of the most unusual," said Jammin' Joseph Larue. "Getting professional eaters to lose weight... it's like asking fish to walk or librarians to scream."

"We relish the opportunity to watch these expert eaters tackle a different kind of food-related competition. We're curious to see what they do to fill the time. Maybe Joel 'The Cannon' will get into Words With Friends," said Jamie Rosen, DietBet's founder. "Traditionally, 'diet' has been viewed as a four-letter word and we're proving that with DietBet, weight-loss can actually be fun."

About DietBetDietBet is an online social dieting game that gives players the opportunity to win money through weight-loss competitions. Dietbetters play with friends and co-workers and put money into a pot; whoever reaches the goal by the end of four weeks wins the pot (or splits it). It's motivation through friendly competition, with real rewards. Founded by Jamie Rosen and launched in December of 2011, DietBet makes losing weight fun. Find DietBet on Facebook and Twitter.

See original here:
Professional Eaters Devour Giant Pizzas, Then Go on Diet

Posted in Lose Weight Fast | Comments Off on Professional Eaters Devour Giant Pizzas, Then Go on Diet

USDA approves new, genetically modified purple tomato to be sole in American stores next year – WLS-TV

Posted: September 18, 2022 at 2:11 am

It tastes like a tomato, smells like a tomato, and even looks (mostly) like a tomato. There's just one catch: It's purple.

The USDA has approved a genetically modified purple tomato, clearing the path for the unique fruit to be sold in American stores next year.

"From a plant pest risk perspective, this plant may be safely grown and used in breeding," the agency said in a September 7 news release.

The video above is ABC7's 24/7 livestream.

The approval moves the purple tomato one step closer to widespread distribution. In addition to its unique color, the purple tomato also has health benefits and a longer shelf life than garden variety red tomatoes, scientists say.

The tomato was developed by a team of scientists, including British biochemist Cathie Martin, who is a professor at the University of East Anglia and a project leader at the John Innes Centre in Norwich, England.

Martin worked on pigment production in flowers for over 20 years, she told CNN. "I wanted to start projects where we could look and see whether there were health benefits for this particular group of pigments," she said.

The pigments that drew Martin's interest are anthocyanins, which give blueberries, blackberries and eggplants their rich blue-purple hues. With funding from a German consortium, she decided to engineer tomatoes that were rich in anthocyanins, hoping to "increase the antioxidant capacity" of the fruits.

By comparing regular tomatoes to the engineered purple tomatoes, she would be able to easily identify whether the anthocyanins were linked to any specific health benefits.

To engineer the purple tomatoes, the scientists used transcription factors from snapdragons to trigger the tomatoes to produce more anthocyanin, creating a vibrant purple color.

Martin and her colleagues published the first results of their research in 2008 in an article in Nature Biotechnology.

The results were "stunning," she said. Cancer-prone mice that ate the purple tomatoes lived around 30% longer than those that ate normal tomatoes, according to the study.

Martin said there are "many explanations" as to why anthocyanin-rich tomatoes may have health benefits. There are "probably multiple mechanisms involved," she said. "It's not like a drug, where there's a single target. It's about them having antioxidant capacity. It also may influence the composition of the microbiome, so it's better able to deal with digestion of other nutrients."

And in 2013, Martin and colleagues released a study that found the purple tomatoes had double the shelf life of their red cousins.

Martin established a spinout company, Norfolk Plant Sciences, to bring the purple tomatoes to market. Nathan Pumplin, the CEO of Norfolk's US-based commercial business, told CNN that the purple tomato "strikes a cord with people in this very basic way."

The distinctive purple color means that "it takes no imagination to see that it's different," Pumplin said. "It really allows people to make a choice."

In the past, forays into genetically modified foods have often focused on engineering crops that are more sustainable to produce, he added. But for consumers, the benefits of eating a genetically modified food are murky.

"It's very abstract, hard to understand," Pumplin said. "But a purple tomato -- you either choose or choose not to consume." The difference between the GMO (Genetically Modified Organism) product and the non-modified tomato are stark -- and the possible health benefits for consumers are also clear.

Pumplin says that consumers are "warming up" to genetically modified foods across the world.

"We look at the problems facing our society as far as sustainability, climate change, health tied to diet and nutrition, and what's clear from the response from our announcement is that it's a really important topic to a lot of people," he said. "I'm encouraged that a lot of people are starting to relook at biotechnology in light of the important challenges."

At the same time, "GMOs are not a silver bullet," he said. "It's one tool in our toolbox as plant scientists, as scientists, agronomists, to improve the food production system."

The next steps for the purple tomato are FDA approval and commercialization, Pumplin said. "We need to breed excellent, delicious purple tomatoes. We need to work with producers to produce them and distribute them."

Norfolk will begin to launch limited test markets in 2023 to identify which consumers are most interested in purple tomatoes.

As for the taste? The purple tomato is indistinguishable from your standard red tomato, Pumplin said.

"It tastes like a great tomato," he said.

(The-CNN-Wire & 2022 Cable News Network, Inc., a Time Warner Company. All rights reserved.)

Read the rest here:
USDA approves new, genetically modified purple tomato to be sole in American stores next year - WLS-TV

Posted in Diet And Food | Comments Off on USDA approves new, genetically modified purple tomato to be sole in American stores next year – WLS-TV

Exploratory analysis of eating- and physical activity-related outcomes from a randomized controlled trial for weight loss maintenance with exercise…

Posted: August 17, 2022 at 2:05 am

Nordmo M., Danielsen Y. S., & Nordmo M. The challenge of keeping it off, a descriptive systematic review of high-quality, follow-up studies of obesity treatments. Obes. Rev. 21, 12949 (2020).

Rosenbaum, M., Hirsch, J., Gallagher, D. A. & Leibel, R. L. Long-term persistence of adaptive thermogenesis in subjects who have maintained a reduced body weight. Am. J. Clin. Nutr. 88, 906912 (2008).

CAS PubMed Article Google Scholar

Leibel, R. L., Rosenbaum, M. & Hirsch, J. Changes in energy expenditure resulting from altered body weight. N. Engl. J. Med 332, 621628 (1995).

CAS PubMed Article Google Scholar

Polidori, D., Sanghvi, A., Seeley, R. J. & Hall, K. D. How Strongly Does Appetite Counter Weight Loss? Quantification of the Feedback Control of Human Energy Intake. Obesity 24, 22892295 (2016).

CAS PubMed Article Google Scholar

Iepsen, E. W., Lundgren, J., Holst, J. J., Madsbad, S. & Torekov, S. S. Successful weight loss maintenance includes long-term increased meal responses of GLP-1 and PYY3-36. Eur. J. Endocrinol. 174, 775784 (2016).

CAS PubMed Article Google Scholar

Nymo, S. et al. Investigation of the long-term sustainability of changes in appetite after weight loss. Int J. Obes. 42, 14891499 (2018).

CAS Article Google Scholar

Christensen, B. J. et al. Instrumentalization of Eating Improves Weight Loss Maintenance in Obesity. Obes. Facts 10, 633647 (2017).

PubMed PubMed Central Article Google Scholar

Jebb S. A. & Moore M. S. Contribution of a sedentary lifestyle and inactivity to the etiology of overweight and obesity: Current evidence and research issues. Med. Sci. Sports Exerc. 31 S53441 (1999).

Kernen, A. M. et al. The effect of eating behavior on weight loss and maintenance during a lifestyle intervention. Prev. Med (Balt.) 49, 3238 (2009).

Article Google Scholar

Blundell, J. E. & Finlayson, G. Is susceptibility to weight gain characterized by homeostatic or hedonic risk factors for overconsumption? Physiol. Behav. 82, 2125 (2004).

CAS PubMed Article Google Scholar

Mayer, J., Roy, P. & Mitra, K. P. Relation between caloric intake, body weight, and physical work: studies in an industrial male population in West Bengal. Am. J. Clin. Nutr. 4, 169175 (1956).

CAS PubMed Article Google Scholar

Stubbs, R. J. et al. A decrease in physical activity affects appetite, energy, and nutrient balance in lean men feeding ad libitum. Am. J. Clin. Nutr. 79, 6269 (2004).

CAS PubMed Article Google Scholar

Hu, F. B., Li, T. Y., Colditz, G. A., Willett, W. C. & Manson, J. A. E. Television Watching and Other Sedentary Behaviors in Relation to Risk of Obesity and Type 2 Diabetes Mellitus in Women. J. Am. Med Assoc. 289, 17851791 (2003).

Article Google Scholar

Redman, L. M. et al. Metabolic and Behavioral Compensations in Response to Caloric Restriction: Implications for the Maintenance of Weight Loss. PLoS One 4, e4377 (2009).

ADS PubMed PubMed Central Article CAS Google Scholar

Melanson, E. L., Keadle, S. K., Donnelly, J. E., Braun, B. & King, N. A. Resistance to exercise-induced weight loss: Compensatory behavioral adaptations. Med Sci. Sports Exerc 45, 16001609 (2013).

PubMed PubMed Central Article Google Scholar

Flint, A., Raben, A., Astrup, A. & Holst, J. J. Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. J. Clin. Invest 101, 515520 (1998).

CAS PubMed PubMed Central Article Google Scholar

Van Can, J. et al. Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults. Int J. Obes. 38, 784793 (2014).

Article CAS Google Scholar

Horowitz, M. et al. Effect of the once-daily human GLP-1 analogue liraglutide on appetite, energy intake, energy expenditure and gastric emptying in type 2 diabetes. Diabetes Res Clin. Pr. 97, 258266 (2012).

ADS CAS Article Google Scholar

Iepsen, E. W. et al. Patients with Obesity Caused by Melanocortin-4 Receptor Mutations Can Be Treated with a Glucagon-like Peptide-1 Receptor Agonist. Cell Metab. 28, 2332.e3 (2018).

CAS PubMed Article Google Scholar

Blundell, J. et al. Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity. Diabetes, Obes. Metab. 19, 12421251 (2017).

CAS Article Google Scholar

Tronieri, J. S. et al. Effects of liraglutide on appetite, food preoccupation, and food liking: results of a randomized controlled trial. Int J. Obes. 44, 353361 (2020).

CAS Article Google Scholar

King, N. A. et al. Dual-process action of exercise on appetite control: Increase in orexigenic drive but improvement in meal-induced satiety. Am. J. Clin. Nutr. 90, 921927 (2009).

CAS PubMed Article Google Scholar

Beaulieu, K., Oustric, P. & Finlayson, G. The Impact of Physical Activity on Food Reward: Review and Conceptual Synthesis of Evidence from Observational, Acute, and Chronic Exercise Training Studies. Curr. Obes. Rep. 9, 6380 (2020).

PubMed PubMed Central Article Google Scholar

Hopkins, M. et al. Activity energy expenditure is an independent predictor of energy intake in humans. Int J. Obes. 43, 14661474 (2019).

Article Google Scholar

Blundell, J. E. et al. Role of resting metabolic rate and energy expenditure in hunger and appetite control: A new formulation. DMM Dis. Model. Mech. 5, 608613 (2012).

PubMed Article Google Scholar

Lundgren, J. R. et al. Healthy Weight Loss Maintenance with Exercise, Liraglutide, or Both Combined. N. Engl. J. Med 384, 171930 (2021).

PubMed Article Google Scholar

Jensen, S. B. K. et al. Protocol for a randomised controlled trial of the combined effects of the GLP-1 receptor agonist liraglutide and exercise on maintenance of weight loss and health after a very low-calorie diet. BMJ Open 9, e031431 (2019).

PubMed PubMed Central Article Google Scholar

Finlayson, G., Arlotti, A., Dalton, M., King, N. & Blundell, J. E. Implicit wanting and explicit liking are markers for trait binge eating. A susceptible phenotype for overeating. Appetite 57, 722728 (2011).

PubMed Article Google Scholar

Griffioen-Roose, S., Finlayson, G., Mars, M., Blundell, J. E. & de Graaf, C. Measuring food reward and the transfer effect of sensory specific satiety. Appetite 55, 648655 (2010).

PubMed Article Google Scholar

Angl, S. et al. Three factor eating questionnaire-R18 as a measure of cognitive restraint, uncontrolled eating and emotional eating in a sample of young Finnish females. Int J. Behav. Nutr. Phys. Act. 6, 41 (2009).

PubMed PubMed Central Article Google Scholar

Hall, K. D. & Kahan, S. Maintenance of Lost Weight and Long-Term Management of Obesity. Med. Clin. North Am. 102, 183197 (2018).

PubMed PubMed Central Article Google Scholar

Sumithran, P. et al. Long-term persistence of hormonal adaptations to weight loss. N. Engl. J. Med 365, 15971604 (2011).

CAS PubMed Article Google Scholar

de Groot, L. C., van Es, A. J., van Raaij, J. M., Vogt, J. E. & Hautvast, J. G. Adaptation of energy metabolism of overweight women to alternating and continuous low energy intake. Am. J. Clin. Nutr. 50, 13141323 (1989).

PubMed Article Google Scholar

Graham, A. L., Gluck, M. E., Votruba, S. B., Krakoff, J. & Thearle, M. S. Perseveration augments the effects of cognitive restraint on ad libitum food intake in adults seeking weight loss. Appetite 82, 7884 (2014).

PubMed PubMed Central Article Google Scholar

Lachin, J. M. Statistical considerations in the intent-to-treat principle. Control Clin. Trials 21, 167189 (2000).

CAS PubMed Article Google Scholar

De Lauzon, B. et al. The Three-Factor Eating Questionnaire-R18 is able to distinguish among different eating patterns in a general population. J. Nutr. 134, 23722380 (2004).

PubMed Article Google Scholar

Flint, A., Raben, A. & Blundell, J. E. Astrup A. Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies. Int J. Obes. 24, 3848 (2000).

CAS Article Google Scholar

Migueles, J. H., Rowlands, A. V., Huber, F., Sabia, S. & van Hees, V. T. GGIR: A Research CommunityDriven Open Source R Package for Generating Physical Activity and Sleep Outcomes From Multi-Day Raw Accelerometer Data. J. Meas. Phys. Behav. 2, 188196 (2019).

Article Google Scholar

Van Hees, V. T. et al. Autocalibration of accelerometer data for free-living physical activity assessment using local gravity and temperature: An evaluation on four continents. J. Appl Physiol. 117, 738744 (2014).

PubMed PubMed Central Article Google Scholar

van Hees, V. T. et al. Separating Movement and Gravity Components in an Acceleration Signal and Implications for the Assessment of Human Daily Physical Activity. PLoS One 8, e61691 (2013).

ADS PubMed PubMed Central Article CAS Google Scholar

Doherty, A. et al. Large scale population assessment of physical activity using wrist worn accelerometers: The UK biobank study. PLoS One 12, e0169649 (2017).

PubMed PubMed Central Article CAS Google Scholar

Sabia, S. et al. Association between questionnaire-and accelerometer-assessed physical activity: The role of sociodemographic factors. Am. J. Epidemiol. 179, 781790 (2014).

PubMed PubMed Central Article Google Scholar

Booth, M. Assessment of physical activity: An international perspective. Res Q Sport Exerc 71, 114120 (2000).

Article Google Scholar

Bull, F. C. et al. World Health Organization 2020 guidelines on physical activity and sedentary behaviour. Br. J. Sports Med 54, 14511462 (2020).

PubMed Article Google Scholar

Link:
Exploratory analysis of eating- and physical activity-related outcomes from a randomized controlled trial for weight loss maintenance with exercise...

Posted in Lose Weight Fast | Comments Off on Exploratory analysis of eating- and physical activity-related outcomes from a randomized controlled trial for weight loss maintenance with exercise…

Promoting adherence to r-hGH therapy | PPA – Dove Medical Press

Posted: July 16, 2022 at 2:00 am

Martin O Savage,1 Luis Fernandez-Luque,2 Selina Graham,3 Paula van Dommelen,4 Matheus Araujo,5 Antonio de Arriba,6 Ekaterina Koledova7

1Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine & Dentistry, London, UK; 2Adhera Health Inc., Palo Alto, CA, USA; 3Kings College London, London, UK; 4The Netherlands Organization for Applied Scientific Research TNO, Leiden, the Netherlands; 5Neurological Institute; Cleveland Clinic, Cleveland, OH, USA; 6Paediatric Endocrinology, Hospital Universitario Miguel Servet, Zaragoza, Spain; 7Global Medical Affairs Cardiometabolic & Endocrinology, Merck Healthcare KGaA, Darmstadt, Germany

Correspondence: Martin O Savage, Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine & Dentistry, Charterhouse Square, London, EC1M 6BQ, UK, Tel +44 7803084491, Email [emailprotected]

Abstract: Pediatric growth hormone (GH) deficiency is a licensed indication for replacement therapy with recombinant human growth hormone (r-hGH). Treatment, consisting of daily subcutaneous injections, extends from the time of diagnosis until cessation of linear growth at completion of puberty. Suboptimal adherence to r-hGH therapy is common and has been well documented to substantially impair the growth response and achievement of the optimal goal which is attainment of adult height within the genetic target range. The causes of poor adherence are complex and include disease-, patient-, doctor-, and treatment-related factors. Interventions for suboptimal adherence are important for a long-term successful outcome and can include both face-to-face and digital strategies. Face-to-face interventions include behavioral change approaches such as motivational interviewing and non-judgmental assessment. Medical and nursing staff require training in these techniques. Digital solutions are rapidly advancing as evidenced by the electronic digital auto-injector device, easypod (Merck Healthcare KGaA, Darmstadt, Germany), which uses the web-based easypod connect platform allowing adherence data to be transmitted electronically to healthcare professionals (HCPs), who can then access GH treatment history, enhancing clinical decisions. Over the past 10 years, the multi-national Easypod Connect Observational Study has reported high levels of adherence (> 85%) from up to 40 countries. The easypod connect system can be supported by a smartphone app, growlink, which facilitates the interactions between the patients, their care team, and patient support services. HCPs are empowered by new digital techniques, however, the humandigital partnership remains essential for optimal growth management. The pediatric patient on r-hGH therapy will benefit from these innovations to enhance adherence and optimize long-term response.

Adherence to a therapeutic regimen is an essential component of the success of any prescribed therapy. In the case of treatment of pediatric growth disorders, prescribed therapy in the form of recombinant human growth hormone (r-hGH) will generally be started in early childhood when the child presents with short stature and continued for many years. The aim is to normalize height during childhood and adolescence and achieve an adult height consistent with the genetic target of the family.1 Such a therapeutic regimen, consisting of daily subcutaneous injections lasting for many years, places a considerable psychological and physical burden on the patient to adhere. There is also a pressure on healthcare professionals (HCPs) responsible for this care to induce a beneficial long-term result.2

Two important considerations linked to good adherence to r-hGH are necessary for optimal outcomes. These are, first, the extent to which the patients behavior matches agreed recommendations from their HCP and, second, persistence with the therapy, ie lack of discontinuation.3 Adherence can be defined as the extent to which the patient follows a prescribed therapeutic regimen and, in the case of r-hGH, the extent to which daily r-hGH injections are taken. The success of r-hGH therapy, as in other chronic conditions, is thought to be dependent on the patients ability to maximally adhere to their treatment regimen.2,3

In this review, we will discuss the challenges, both to the patient and HCP, of maintaining a high level of adherence to r-hGH, and the factors which have been shown to influence adherence both negatively and positively. We will summarize feedback data from both HCPs and patients, and discuss knowledge from other more advanced therapeutic areas regarding the importance of data generation and analysis to understand how to positively support adherence. Our aim is to look forward to future developments in digital health which will positively impact on adherence. We will discuss the contribution of behavioral support and its digitalization as a means of supporting the family and patient, and conclude by debating the importance of design of adherence support, with continuous evaluation cycles of new digital tools, in order to achieve maximal personalized impact on the adherence paradigm and the patients journey.

Since the development and widespread clinical use of r-hGH in 1985, a range of growth disorders have been approved for this treatment by regulatory organizations such as the US Food and Drug Administration and European Medicines Agency.4 Initially, GH deficiency (GHD) was approved, followed by non-GH-deficient disorders such as Turner syndrome, short stature related to birth size small for gestational age (SGA), and idiopathic short stature.5 Treatment of these disorders until adult height is reached is, by definition, demanding and the issue of good adherence to the prescribed therapy is highly relevant to the final outcome.6

Thus, begins a multi-year journey involving daily injections and regular consultation visits (typically every 6 months) to assess growth and metabolic parameters. Along this journey and depending on the healthcare setting, the child and his/her parents receive various levels of information, support, and encouragement to comply with the therapy regimen. HCPs may also be involved in dealing with clinical, emotional, and behavioral issues that may arise during teenage years. Adolescents with GHD may require transitional care and continued r-hGH therapy through into adulthood to optimize body composition maturation and metabolic factors that could adversely affect their cardiovascular health.7,8

Factors adversely affecting adherence which are encountered by HCPs include managing clinical, emotional, and behavioral issues arising during teenage years.9 Other factors shown to be strongly associated with non-adherence and lack of persistence include poor understanding of both the condition and consequences of missed r-hGH doses, injection discomfort, dissatisfaction with growth outcomes compared with pediatric endocrinologist predictions, and inadequate or problematic contact with HCPs.10

Digital health technologies have become an essential part of daily life and, consequently, they have high potential to support patients and caregivers in their health management. As early as 1996, research showed the positive impact of digital tools in diabetes patient education for children.11 However, the wider adoption and implementation of such technologies is still a major challenge.12 The scientific community has been looking into many factors that address adoption and acceptance of technologies and these often highlight human factors such as usability, perceived usefulness, and literacy levels.13,14 These factors related to the adoption of technology have some similarities to drivers for medication adherence,1517 including education or how the medication is being introduced.

Addressing the patients and caregivers perspectives is crucial, especially in areas where digital health interventions are supporting medication adherence or other long-term self-management behaviors. In the case of digital interventions in pediatrics, a key aspect to consider is the interplay between caregivers and patients especially during the transition to adult care18 or patient-initiated medication. For example, a key moment to intervene is when injections are transitioning from being delivered by the caregivers to the children themselves.

In recent years, a lot of effort has been put into the use of new methodologies to capture end-users feedback when using digital interventions, including participatory research and design research.19 Such methodologies facilitate the capture of feedback and the perspective of patients and caregivers for adjusting behavioral interventions.20 This feedback can then be used to adjust digital interventions to minimize adoption challenges. For example, the project Sisom (from the Norwegian phrase Si det Som det er, meaning Tell it how it is) focused on capturing the feedback of children with chronic conditions using a child-friendly patient-reported outcome mobile solution designed to enhance nursepatient relationships.21 Another example is the mobile solution Pain Squad for children with oncologic pain, for example, where patients were heavily involved in the design to maximize adherence to the use of the mobile-based pain diary.22 A more recent example, explained below, is the CARING study which focuses on the feasibility of supporting the emotional wellbeing of caregivers in a mobile-based digital intervention.23

Several factors are important when capturing feedback from patients and caregivers for the development of digital health interventions. Studies have shown that socio-cultural factors such as gender, ethnicity, and education level are relevant in the adoption of such digital health technologies.2426 Also, caregivers and patients perspectives concerning digital health interventions should be included in the analysis of healthcare delivery since, in most cases, the roll-out and implementation of such solutions will impact the provision of healthcare. To address this service delivery angle, methods aligned with service design are often applied.14 Finally, emerging research highlights the relevance of addressing digital health literacy as an enabler for adoption. Consequently, it represents a major aspect to consider when studying the patients and caregivers perspectives. For example, high levels of digital health literacy reduce risks regarding the adoption and safe usage of digital health tools by both caregivers and patients.27

There are several ways of administering r-hGH to pediatric patients, including syringes, pens, and auto-injector devices. One such device, the easypod autoinjector, transmits data to a web-based platform that allows HCPs to monitor adherence and access longitudinal patient data. To test the impact of this digital ecosystem on adherence, the Easypod Connect Observational Study (ECOS) was performed across multiple countries.28 The ECOS demonstrated how a digital health ecosystem, that records dose, date, and time of r-hGH administration, can help to maintain high adherence (85%; mg injected/mg prescribed) over the course of several years in different countries.28 Real-world data extracted from the easypod connect ecosystem support these findings. In an analysis performed from 2007 to the end of 2020, adherence data were available for 20,264 patients from 38 countries.29,30 Levels of high adherence increased over time in European (76% in 2010; 8284% in 20152019; 86% in 2020), North American (Canadian) (65% in 2010; 68% in 2015; 88% in 20192020), and Asian (5862% in 20142015; 6873% in 20162020) patients.29,30 No consistent change in adherence was found among Latin-American and Caribbean patients.29,30 Importantly, the observed adherence levels also had a statistically significant effect on change in Height Standard Deviation Scores (HSDS) from treatment start. Mean HSDS were 0.4, 0.7, 1.0, and 1.1 after 12, 24, 36, and 48 months treatment, respectively, in patients with high (85%) monthly adherence, 0.3, 0.6, 0.8, and 0.9 in patients with intermediate (>5684%) monthly adherence and 0.2, 0.5, 0.6, and 0.7 in patients with low (56%) monthly adherence.29,30

Expansion of digital health ecosystems, like easypod connect, through addition of new digital tools that have been co-created with HCPs and patients, offers an exciting opportunity to further improve both adherence and clinical outcomes for patients with growth disorders. When developing such digital tools, we propose following an iterative cycle that leverages the use of patient-generated data (Figure 1). The approach implies that defined hypotheses are validated based on patient-generated data prior to the design of prototypes, which are then tested in a clinical setting as the basis for future hypotheses. This continuous feedback loop can help pinpoint areas for improvement based on pre-defined patient populations. First, a team of interdisciplinary HCPs defines a hypothesis to improve management towards an optimal outcome based on their clinical experience. For example, they propose a mathematical model that predicts future therapy response based on experience and demographic information. Once the hypothesis has been thoroughly defined, data scientists use information from connected devices and other data sources, such as electronic health records, to develop, analyze, and validate data-driven models in an experimental setting. If successful, an experimental model (prototype) is designed and tested in collaboration with the HCP team, taking end-user feedback into consideration. An enhanced digital ecosystem is then established as the basis for real-world evaluation of (determinants) of use and outcome, for example, in prospective clinical trials. This enhanced ecosystem not only has the potential to improve disease management, but also serves as the basis for hypothesis generation within the next iterative loop. Over time, with increased patient-generated datasets, improved synergy between experienced teams, and new assumptions and hypotheses, this agile and incremental approach to the development of digital ecosystems will reflect the evolution of healthcare provision.

Figure 1 Continuous feedback loop based on patient-generated data. The data provided by patients, the HCP team and data scientists contribute to the development of an enhanced ecosystem.

To complement digital solutions, the use of psychology-based approaches within the healthcare environment can be beneficial to support HCPs in learning how to help patients to make healthy choices and decisions in their lives. HCPs are uniquely positioned within clinical settings to monitor, support, and promote adherence behaviors due to their existing supporting relationships with patients and their families.31 Importantly, HCPs are trusted by their patients and are often the people patients will turn to when they are thinking about making a health-related change. Addressing adherence-related issues within routine clinical practice can be a struggle, as patients and/or their families generally find it difficult to talk openly about adherence and are often reluctant or apprehensive to disclose treatment non-adherence.32 Thus, it is important for medical and nursing HCPs to be supported in core training to develop and reinforce key consultation behaviors and skills, ie motivational interviewing (MI).33

MI is a skill which can benefit both medical and nursing HCPs. Examples of the benefits of MI can be taken from experience in making healthy life choices. When considering these choices, reaction to the individual can be unhelpful, such as not listening or negatively encouraging regressive behavior. By contrast, a helpful response to the same life choices would consist of positive reactions such as genuine empathetic listening and exploration of the individuals feelings without judgement. This behavior typifies the spirit of MI, the key principles of which are partnership, acceptance, compassion, and evocation (PACE). Collaboration is important because partnership on an equal level with the patient is a key aim. Acceptance leads to better understanding of the decisions and choices that patients and families are making without judgement. These choices are accepted and the HCP responds with guidance. Compassion is a further component that is combined with Evocation, which means drawing out a patients inner motivation and commitment, and building on this to effect change.2,33

Core skills in MI can be discussed under the acronym OARS, which stands for Open questions, Affirmations, Reflective listening, and Summarising.2,33 The conversation can be structured by following these headings. Open questions such as what, how, and why will open conversations and evoke dialogue. Other examples would be what are your hopes for your consultation today? and I am curious to learn how you have been getting on with your injections? These questions can be prefaced by saying help me understand and the conversation can develop by inviting the patient or family to talk about what is on their mind and what their needs and their priorities are. Affirmations are about helping patients to recognize their own strengths and positive beliefs that are going to help them to adhere to r-hGH therapy. Examples could be to say to a patient, I can see it took courage for you to try this out today or to a parent, your creative ideas around this are very helpful. Reflective listening consists of not only listening and reflecting back what is said, it also helps in verbalizing the thinking and feelings that lie underneath, showing a depth of empathy that leads to further conversations. The last skill here is summarizing, which serves the useful purpose of wrapping up conversations and can be started by saying let me see if I have got this right, you are feeling this on one hand and perhaps feeling this on the other?.

Pediatric endocrinology nurse specialists can play a key role in addressing and managing the needs of patients prescribed r-hGH treatment and their families within their medical consultations. In view of this, psychologically-based patient support programs (PSPs) have been designed to help support patients and families to better manage their condition and treatment, with the purpose to optimize treatment adherence and improve clinical outcomes. These programs have demonstrated improved outcomes in a wide variety of diseases, through multidisciplinary HCP training and coaching; therefore, it is crucial for HCPs to begin to implement these new approaches within clinical practice in order to make a positive impact.34,35

One such PSP is TuiTek, a digital, multicomponent, personalized program designed to support the needs of patients, caregivers, and HCPs throughout the treatment care pathway. The intervention comprises two key service components: 1) a PSP training session, which aims to provide the HCP with the tools and strategies to deliver the TuiTek PSP and 2) a PSP Manual, consisting of A) a personalization screener, for HCPs to identify the key issues and challenges faced by patients and caregivers, and tailor the patient support; and B) a set of personalized one-to-one telephone call guides and resource packs which utilize a range of behavior change techniques (BCTs) and principles of MI, to support the HCP to engage in high-quality adherence-focused conversations with the patient during scheduled outbound calls with caregivers.

HCP-led calls which use BCTs and implement MI principles have been shown to affect meaningful behavior change across different health conditions such as increasing physical activity and improving diet,36,37 as well as demonstrating a positive impact on treatment adherence.38 This aligns with the findings of the TuiTek PSP which has been shown to positively address disease- and treatment-related barriers amongst caregivers regarding optimal adherence of their children to GH treatment; this, in turn, has the potential to improve adherence levels and patient clinical health outcomes.

Caregiver emotional distress has been found to be a driver of poor adherence and self-management skills in pediatrics and growth disorders.3941 This includes aspects related to anxiety and fear of the medication itself, but also aspects such as poor communication between parents and children. Overall, poor emotional wellbeing has a direct impact on the self-efficacy of both caregivers and patients themselves which ultimately will drive poor self-management behaviors.

There is a body of literature in pediatrics showing the efficacy of interventions to address the emotional wellbeing of caregivers of children living with chronic conditions. These include the use of techniques such as cognitive behavioral therapy and mindfulness.42,43 As a result, caregivers are better equipped to handle emotional stressors. Also, there is evidence of the positive impact of enhancing parenting skills such as communication to help cope with stressful situations related to the self-management of a chronic condition.44

In the CARING study, a digitally enabled intervention was designed and implemented to complement the work of the pediatric endocrinology unit in the University Hospital of Miguel Servet in Zaragoza, Spain.23 The clinicians identified children with suboptimal adherence using the easypod connect platform, their caregivers were then invited to participate in a study that includes the use of a digital program to deliver an intervention designed to improve the mental wellbeing of caregivers.

The digital intervention was powered by the ADHERA CARING platform that incorporates educational content to improve self-management skills, including gamification elements (eg quizzes), and is designed to ensure understandability and usability. This is complemented by content addressing mental-wellbeing based on cognitive behavioral therapy, including content such as videos of relaxation techniques aimed at helping families to reduce anxiety before injections. Furthermore, tailored motivational messages were sent to caregivers to reinforce engagement and therapeutic effectiveness. The behavioral design of the intervention was based on the Integrated Model for Behavioral Change (I-CHANGE).20

The first phase of the study included the recruitment of 10 caregivers who tested the program for a month and provided feedback in a semi-structured interview. The qualitative feedback data was used to identify areas for improvement and adjustment of the intervention prior to starting the second phase of the study which is aimed at quantifying the clinical impact of such an intervention. The preliminary results achieved in the first phase of the study showed high engagement and positive feedback; in addition, participants highlighted the importance of such interventions not only when adherence is suboptimal but also at the initiation of the treatment.23

There are several unmet clinical needs related to the management of a child with GHD. The first is the late age of diagnosis. In a recent study of 39 children with GHD, the mean age of diagnosis was 4.6 years in Germany, 7.0 years in the UK, and 9.4 years in the USA.45 The late age of diagnosis has a negative impact on the adult height achieved after r-hGH therapy.1 The subjects with abnormal variables are sent for investigation and diagnosis.46 Such a technique of height screening has not yet been demonstrated to work in a real-world busy inner-city environment.

A second unmet need relates to the poor quality of growth response to r-hGH therapy, for which there are a wide range of causes. Therapy needs to be individualized, in terms of starting dose, for every child starting therapy. The one-dose-fits-all philosophy which was widely practiced in the 1980s and 1990s can no longer be defended and is inconsistent with the current standards of precision medicine.47 Many children are receiving inadequate doses of r-hGH with a lack of sophisticated dose individualization taking into consideration the known predictive factors.48 In addition, GH responsiveness may be affected by influences outside the GH-IGF-1 axis such as genetic variants which can induce a degree of GH resistance.49 In these subjects, r-hGH therapy should logically be discontinued. The range of responses to r-hGH also extends to children with more severe GH deficiency, who respond well to r-hGH doses below the recommended dose. A third unmet need relates to patients displaying poor adherence to r-hGH therapy, as discussed in this article.

Finally, the standard of transitional care of the adolescent with GHD after completion of linear growth from pediatric to adult care is highly variable between centers and countries.50 Several digital tools are available to assess a young patients readiness for transition, including the Transition Readiness Assessment Questionnaire. This has been used in endocrinology to compare young people with Turner syndrome to those with type 1 diabetes, and revealed that those with Turner syndrome are less mature in the management of their healthcare and may find the process of transfer to adult services difficult.51 This aspect is, however, also connected with national healthcare policies. Mobile devices, such as smartphone apps (e.g. Tiny Medical Apps Digital Health Passport app), have been developed that can assist young people in self-managing their condition.

We believe that supporting patients across their disease journey means more than just providing them and their physicians with an effective therapy. Beyond the prescription of r-hGH, it means providing all stakeholders involved with the tools, information, services, and support needed to achieve the goal of effective treatment and clinical benefit. Methods for assessment of adherence need to be standardized, both from the point of view of definition of adherence and its measurement.52 For GH-deficient patients, caregivers, and HCPs, this has meant a change in the attitude towards r-hGH adherence and embracing the concept of a successful humandigital partnership which is essential to achieve these goals.2 The relationship between poor adherence and poor response to r-hGH therapy is well established.53 While enthusiasm and support for digital health technologies was slow at first, these efforts have accelerated with broader awareness and acceptance amongst both patients and HCPs. New digital technologies will evolve and the introduction of innovations and new technologies, while providing challenges for patients and HCPs, have the potential to further improve the personalized management of the GH-deficient patient receiving r-hGH therapy. The development of digital ecosystems reflecting the evolution of healthcare provision and an agile incremental approach of their enhancements by Iterative loops has the potential to improve disease management.

Editorial assistance was provided by Amy Evans of inScience Communications, Springer Healthcare Ltd, UK, and was funded by Merck Healthcare KGaA, Darmstadt, Germany.

This study was sponsored by Merck (CrossRef Funder ID: 10.13039/100009945).

MOS has consultancy agreements with Merck Healthcare KGaA Darmstadt and Pfizer as well as honoraria for lectures from Ipsen, GeneSciences, and Sandoz. LF-L is Chief Scientific Officer at Adhera Health Inc., Palo Alto, CA, USA. SG and PvD have consultancy agreements with Merck. MA has previously had a consultancy agreement with Merck. AdA does not have any conflicts of interest to declare. EK is an employee of Merck Healthcare KGaA, Darmstadt, Germany and holds shares in the company. The authors report no other conflicts of interest in this work.

1. Wit JM, Deeb A, Bin-Abbas B, Al Mutair A, Koledova E, Savage MO. Achieving optimal short- and long-term responses to paediatric growth hormone therapy. J Clin Res Pediatr Endocrinol. 2019;11(4):329340. doi:10.4274/jcrpe.galenos.2019.2019.0088

2. Child J, Davies C, Frost K, et al. Managing paediatric growth disorders: integrating technology into a personalised approach. J Clin Res Pediatr Endocrinol. 2020;12(3):225232.

3. Fisher BG, Acerini CL. Understanding the growth hormone therapy adherence paradigm: a systematic review. Horm Res Paediatr. 2013;79(4):189196. doi:10.1159/000350251

4. Dattani M, Malhotra N. A review of growth hormone deficiency. Paediatr Child Health. 2019;29:285292. doi:10.1016/j.paed.2019.04.001

5. Ranke MB, Wit JM. Growth hormone - past, present and future. Nat Rev Endocrinol. 2018;14(5):285300. doi:10.1038/nrendo.2018.22

6. Dimitri P, Fernandez-Luque L, Banerjee I, et al. An eHealth framework for managing pediatric growth disorders and growth hormone therapy. J Med Internet Res. 2021;23(5):e27446. doi:10.2196/27446

7. Kuromaru R, Kohno H, Ueyama N, Hassan HM, Honda S, Hara T. Long-term prospective study of body composition and lipid profiles during and after growth hormone (GH) treatment in children with GH deficiency: gender-specific metabolic effects. J Clin Endocrinol Metab. 1998;83(11):38903896. doi:10.1210/jcem.83.11.5261

8. Johannsson G, Albertsson-Wikland K, Bengtsson BA. Discontinuation of growth hormone (GH) treatment: metabolic effects in GH-deficient and GH-sufficient adolescent patients compared with control subjects. Swedish study group for growth hormone treatment in children. J Clin Endocrinol Metab. 1999;84(12):45164524. doi:10.1210/jcem.84.12.6176

9. Taddeo D, Egedy M, Frappier JY. Adherence to treatment in adolescents. Paediatr Child Health. 2008;13(1):1924. doi:10.1093/pch/13.1.19

10. Graham S, Weinman J, Auyeung V. Identifying potentially modifiable factors associated with treatment non-adherence in paediatric growth hormone deficiency: a systematic review. Horm Res Paediatr. 2018;90(4):221227. doi:10.1159/000493211

11. Brown SJ, Lieberman DA, Germeny BA, Fan YC, Wilson DM, Pasta DJ. Educational video game for juvenile diabetes: results of a controlled trial. Med Inform. 1997;22(1):7789. doi:10.3109/14639239709089835

12. Stome LN, Wilhelmsen CR, Kvaerner KJ. Enabling guidelines for the adoption of eHealth solutions: scoping review. JMIR Form Res. 2021;5(4):e21357. doi:10.2196/21357

13. El Benny M, Kabakian-Khasholian T, El-Jardali F, Bardus M. Application of the eHealth literacy model in digital health interventions: scoping review. J Med Internet Res. 2021;23(6):e23473. doi:10.2196/23473

14. Shaw J, Agarwal P, Desveaux L, et al. Beyond implementation: digital health innovation and service design. NPJ Digit Med. 2018;1:48. doi:10.1038/s41746-018-0059-8

15. Acerini CL, Segal D, Criseno S, et al. Shared decision-making in growth hormone therapy-implications for patient care. Front Endocrinol. 2018;9:688. doi:10.3389/fendo.2018.00688

16. Assefi AR, Roca F, Rubstein A, Chareca C. Positive impact of targeted educational intervention in children with low adherence to growth hormone treatment identified by use of the easypod electronic auto-injector device. Front Med Technol. 2021;3:609878. doi:10.3389/fmedt.2021.609878

17. World Health Organization. Adherence to long-term therapies: evidence for action; 2003. Available from: https://www.who.int/chp/knowledge/publications/adherence_report/en/. Accessed July 08, 2022.

18. Tornivuori A, Tuominen O, Salantera S, Kosola S. A systematic review on randomized controlled trials: coaching elements of digital services to support chronically ill adolescents during transition of care. J Adv Nurs. 2020;76(6):12931306. doi:10.1111/jan.14323

19. Syed-Abdul S, Zhu X, Fernandez-Luque L. Digital Health. Mobile and Wearable Devices for Participatory Health Applications. 1st ed. Elsevier; 2020.

20. Cheung KL, Hors-Fraile S, de Vries H. How to use the integrated-change model to design digital health programs. In: Syed-Abdul S, Zhu X, Fernandez-Luque L, editors. Digital Health. Mobile and Wearable Devices for Participatory Health Applications. 1st ed. Elsevier; 2021:143157.

21. Arvidsson S, Gilljam BM, Nygren J, Ruland CM, Nordby-Boe T, Svedberg P. Redesign and validation of sisom, an interactive assessment and communication tool for children with cancer. JMIR Mhealth Uhealth. 2016;4(2):e76. doi:10.2196/mhealth.5715

22. Stinson JN, Jibb LA, Nguyen C, et al. Development and testing of a multidimensional iPhone pain assessment application for adolescents with cancer. J Med Internet Res. 2013;15(3):e51. doi:10.2196/jmir.2350

23. Signorelli G, Nunez-Benjumea FJ, Munoz AA, et al. Digital health platform for emotional and self-management support of caregivers of children receiving growth hormone treatment. Stud Health Technol Inform. 2022;289:371375. doi:10.3233/SHTI210936

24. Mitchell UA, Chebli PG, Ruggiero L, Muramatsu N. The digital divide in health-related technology use: the significance of race/ethnicity. Gerontologist. 2019;59(1):614. doi:10.1093/geront/gny138

25. OConnor S, Hanlon P, ODonnell CA, Garcia S, Glanville J, Mair FS. Understanding factors affecting patient and public engagement and recruitment to digital health interventions: a systematic review of qualitative studies. BMC Med Inform Decis Mak. 2016;16(1):120. doi:10.1186/s12911-016-0359-3

26. Rahimi B, Nadri H, Lotfnezhad Afshar H, Timpka T, Systematic A. Review of the technology acceptance model in health informatics. Appl Clin Inform. 2018;9(3):604634. doi:10.1055/s-0038-1668091

27. Magsamen-Conrad K, Wang F, Tetteh D, Lee YI. Using technology adoption theory and a lifespan approach to develop a theoretical framework for eHealth literacy: extending UTAUT. Health Commun. 2020;35(12):14351446. doi:10.1080/10410236.2019.1641395

28. Koledova E, Stoyanov G, Ovbude L, Davies PSW. Adherence and long-term growth outcomes: results from the easypod connect observational study (ECOS) in paediatric patients with growth disorders. Endocr Connect. 2018;7(8):914923. doi:10.1530/EC-18-0172

29. Koledova E, Bagha M, Arnaud L, Piras F, van Dommelen P. Optimising adherence using a connected injection device can improve growth outcomes: evidence from real-world data on 11 million injections in 20,000 patients with growth disorders. Horm Res Paediatr. 2021;94:1445.

30. Tornincasa V, Dixon D, Le Masne Q, et al. Integrated digital health solutions in the management of growth disorders in pediatric patients receiving growth hormone therapy: a retrospective analysis. Front Endocrinol. 2022. doi:10.3389/fendo.2022.882192

31. Abdel-Tawab R, James DH, Fichtinger A, Clatworthy J, Horne R, Davies G. Development and validation of the Medication-Related Consultation Framework (MRCF). Patient Educ Couns. 2011;83(3):451457. doi:10.1016/j.pec.2011.05.005

32. Engel T, Ungar B, Ben-Haim G, Levhar N, Eliakim R, Ben-Horin S. Re-phrasing the question: a simple tool for evaluation of adherence to therapy in patients with inflammatory bowel disease. United European Gastroenterol J. 2017;5(6):880886. doi:10.1177/2050640616687838

33. Miller W, Rollnick S. Applications of Motivational Interviewing. 3rd ed. Guilford Press; 2012.

34. Weingarten SR, Henning JM, Badamgarav E, et al. Interventions used in disease management programmes for patients with chronic illness-which ones work? Meta-analysis of published reports. BMJ. 2002;325(7370):925. doi:10.1136/bmj.325.7370.925

35. Bennett HD, Coleman EA, Parry C, Bodenheimer T, Chen EH. Health coaching for patients with chronic illness. Fam Pract Manag. 2010;17(5):2429.

36. Cook PF, Emiliozzi S, El-Hajj D, McCabe MM. Telephone nurse counseling for medication adherence in ulcerative colitis: a preliminary study. Patient Educ Couns. 2010;81(2):182186. doi:10.1016/j.pec.2009.12.010

37. McBride CM, Rimer BK. Using the telephone to improve health behavior and health service delivery. Patient Educ Couns. 1999;37(1):318. doi:10.1016/S0738-3991(98)00098-6

38. Turner AP, Sloan AP, Kivlahan DR, Haselkorn JK. Telephone counseling and home telehealth monitoring to improve medication adherence: results of a pilot trial among individuals with multiple sclerosis. Rehabil Psychol. 2014;59(2):136146. doi:10.1037/a0036322

39. Silva N, Bullinger M, Sommer R, Rohenkohl A, Witt S, Quitmann J. Childrens psychosocial functioning and parents quality of life in paediatric short stature: the mediating role of caregiving stress. Clin Psychol Psychother. 2018;25(1):e107e118. doi:10.1002/cpp.2146

40. Gerain P, Zech E. Does informal caregiving lead to parental burnout? Comparing parents having (or not) children with mental and physical issues. Front Psychol. 2018;9:884. doi:10.3389/fpsyg.2018.00884

41. Alsaigh R, Coyne I. Mothers experiences of caring for children receiving growth hormone treatment. J Pediatr Nurs. 2019;49:e63e73. doi:10.1016/j.pedn.2019.09.005

42. Segal Z, Teasdale J, Williams J. Mindfulness-based cognitive therapy: theoretical rationale and empirical status. In: Hayes SC, Follette VM, Linehan MM, editors. Mindfulness and Acceptance: Expanding the Cognitive-Behavioral Tradition. Guilford Press; 2004:4565.

43. Townshend K, Jordan Z, Stephenson M, Tsey K. The effectiveness of mindful parenting programs in promoting parents and childrens wellbeing: a systematic review. JBI Database System Rev Implement Rep. 2016;14(3):139180. doi:10.11124/JBISRIR-2016-2314

44. Okafor M, Sarpong D, Ferguson A, Satcher D. Improving health outcomes of children through 10 effective parenting: model and methods. Int J Environ Res Public Health. 2014;11:296311. doi:10.3390/ijerph110100296

45. Brod M, Alolga SL, Beck JF, Wilkinson L, Hojbjerre L, Rasmussen MH. Understanding burden of illness for child growth hormone deficiency. Qual Life Res. 2017;26(7):16731686. doi:10.1007/s11136-017-1529-1

46. Savage MO, Backeljauw PF, Calzada R, et al. Early detection, referral, investigation, and diagnosis of children with growth disorders. Horm Res Paediatr. 2016;85(5):325332. doi:10.1159/000444525

47. Fernandez-Luque L, Al Herbish A, Al Shammari R, et al. digital health for supporting precision medicine in pediatric endocrine disorders: opportunities for improved patient care. Front Pediatr. 2021;9:715705. doi:10.3389/fped.2021.715705

48. Polak M, Konrad D, Tonnes Pedersen B, Puras G, Snajderova M. Still too little, too late? Ten years of growth hormone therapy baseline data from the NordiNet(R) international outcome study. J Pediatr Endocrinol Metab. 2018;31(5):521532. doi:10.1515/jpem-2017-0489

49. Argente J, Tatton-Brown K, Lehwalder D, Pfaffle R. Genetics of growth disorders-which patients require genetic testing? Front Endocrinol. 2019;10:602. doi:10.3389/fendo.2019.00602

50. Colver A, Rapley T, Parr JR, et al. Facilitating transition of young people with long-term health conditions from childrens to adults healthcare services - implications of a 5-year research programme. Clin Med. 2020;20(1):7480. doi:10.7861/clinmed.2019-0077

51. Culen C, Herle M, Ertl DA, et al. Less ready for adulthood?-Turner syndrome has an impact on transition readiness. Clin Endocrinol (Oxf). 2020;93(4):449455. doi:10.1111/cen.14293

52. Gomez R, Ahmed SF, Maghnie M, Li D, Tanaka T, Miller BS. Treatment adherence to injectable treatments in pediatric growth hormone deficiency compared with injectable treatments in other chronic pediatric conditions: a systematic literature review. Front Endocrinol. 2022;13:795224. doi:10.3389/fendo.2022.795224

53. Loftus J, Miller BS, Parzynski CS, et al. Association of daily growth hormone injection adherence and height among children with growth hormone deficiency. Endocr Pract. 2022;28:565571. doi:10.1016/j.eprac.2022.02.013

Originally posted here:
Promoting adherence to r-hGH therapy | PPA - Dove Medical Press

Posted in Human Growth Hormone | Comments Off on Promoting adherence to r-hGH therapy | PPA – Dove Medical Press

Narcolepsy and pregnancy: Risks and what to expect – Medical News Today

Posted: April 11, 2022 at 2:00 am

With the right medical support, people with narcolepsy can have healthy, complication-free pregnancies. However, it is vital to discuss pregnancy plans with a doctor, as a person may need to change or stop their medication.

Certain narcolepsy medications may increase the risk of congenital abnormalities (also known as birth defects). This means that people who are trying to conceive or who are already pregnant may need to manage their symptoms in other ways.

Narcolepsy symptoms can also change or intensify during pregnancy. Most pregnant people experience fatigue due to hormonal changes. These hormonal changes could make narcolepsy symptoms more difficult to manage.

A doctor who specializes in narcolepsy can work with a pregnant person and their obstetrician or midwife to manage symptoms and contribute to a safe pregnancy. Keep reading to learn more about narcolepsy and pregnancy.

Most research to date suggests narcolepsy itself does not negatively affect pregnancy outcomes. A 2013 study of 249 pregnant people in Europe found similar rates of pregnancy complications in those with narcolepsy as in the general population.

However, narcolepsy can affect pregnancy in other ways. For example, people who experience cataplexy may be at risk of falls or injuries, which could affect pregnancy.

Additionally, a 2021 study reports that 94.2% of pregnant people experience fatigue. This fatigue can be intense and may affect daily functioning.

In people with narcolepsy, their symptoms may be more intense than usual. Because of this, pregnant people with narcolepsy require frequent monitoring by a doctor or midwife.

There is not much research on the impact pregnancy has on narcolepsy symptoms. The biggest impact may come from stopping narcolepsy medications, as doing so may make symptoms worse during the pregnancy.

In a 2019 study of pregnant people with narcolepsy, 78.7% stopped taking their medication. To manage the consequences of this:

It is unclear if pregnancy makes any long-term difference to someones narcolepsy symptoms once the pregnancy is over.

The most common narcolepsy medications increase the risk of congenital abnormalities. The risk may be especially high during the first trimester. For this reason, a person may need to stop taking narcolepsy medications before they try to become pregnant.

In a 2020 study of people who took modafinil and armodafinil during pregnancy, the risk of congenital abnormalities in the medication group was 13%, compared with 3% in the general population. Some congenital abnormalities may require pregnancy interventions or a change in delivery plans to keep the baby as safe as possible during birth.

The most common congenital abnormalities included:

In the 2019 study of people with narcolepsy, most participants said they stopped taking medication during past pregnancies, with 82.9% citing fears of harming the fetus as a motivation. 58.5% said their doctor recommended they stop taking medication.

However, some medications may be safe to take during pregnancy, so it is important to discuss all the options with a doctor either before becoming pregnant or at the earliest opportunity after conceiving.

A 2017 study suggests that people who have narcolepsy with cataplexy might have higher rates of gestational diabetes. However, the study was fairly small, involving 25 people who had narcolepsy with cataplexy and 75 who did not have narcolepsy.

Of the participants, 13.6% of people with narcolepsy had gestational diabetes, compared with 4.3% who did not have narcolepsy.

Gestational diabetes may increase the risk of having a very large baby, which in turn can increase the likelihood of:

However, even with the difference in rates, there were no significant differences in pregnancy outcomes between the two groups in the study.

Managing blood sugar levels with diet, lifestyle, and, if necessary, insulin can reduce the risk of complications.

People with narcolepsy can give birth in the same way as others. There is a possibility of cataplexy happening during or after the birth, but medical care and support can ensure people do not fall.

Some people with narcolepsy may choose to have a C-section so that the birth is more controlled, according to 2012 research. This allows people to schedule when birth takes place and may relieve some fears about what will happen if they experience cataplexy during labor.

No specific guidelines suggest that a C-section is the best delivery method for people with narcolepsy or that it leads to better outcomes. Pregnant people should discuss their options with a doctor.

Newborns can wake frequently from sleep and do not sleep according to adult schedules. As a result, many new parents experience periods of sleeplessness and exhaustion. For a person with narcolepsy, this may be even more challenging.

It may help to have a plan in place to ensure that parent and baby are both getting what they need. This may involve:

People with narcolepsy often have healthy pregnancies, and research suggests they are no more likely to experience complications than the rest of the population. However, pregnancy with narcolepsy does come with some unique considerations and challenges.

To make pregnancy and birth as safe as possible, it is best to speak with a doctor before trying to conceive. They can explain the types of support a person might need and whether someone should stop taking their narcolepsy medication. If a person is already pregnant, they should speak with a doctor about this as soon as possible.

Developing a pregnancy and postpartum plan can also be helpful. Try working with a partner, family members, close friends, or a doula to devise and implement strategies to manage the transition to parenthood.

Link:
Narcolepsy and pregnancy: Risks and what to expect - Medical News Today

Posted in Diet And Food | Comments Off on Narcolepsy and pregnancy: Risks and what to expect – Medical News Today

What Is Dry January and What Are the Health Benefits? – Oprah Mag

Posted: January 14, 2022 at 1:52 am

January is often considered a time for New Years resolutions and asking tough questions about your intention for the year to come. And for an increasing number of people, the first month of the year is also an occasion to step back from alcohol consumption. Dry January challenges participants to abstain from drinking alcohol for all 31 days of January.

The challenge first began in 2013 as a public health campaign hosted by the U.K. nonprofit Alcohol for Change. Since that first iteration with 4,000 participants, Dry January has grown to be a part of the cultural lexicon. Nearly 10 years on, the monthlong alcohol detox is practically a movement, with nearly 20 percent of adults in the U.S. saying they plan to participate in 2022s, per a Morning Consult poll.

Following what is, for many, a period of holiday indulgences, Dry January may act as a reset button. According to a 2019 study from the University of Sussex, other reasons participants take on the challenge typically include improving their health, proving to themselves they could do it, losing weight, and cutting back on spending money.

Studies show that reducing alcohol intake has proven health benefits, like lowered blood pressure, improved sleep, and a reduced risk of liver disease. As for the efficacy of Dry January? Well, nutritionist Keri Gans, MS RDN CDN, explains that noticeable benefits vary by participantand have to do with how much you were drinking before January. According to the CDC, one drink per day is considered moderate drinking for women, and two per day for men. People are more likely to see changes if they were drinking more than that amount, Gans says.

In that sense, Dry January is an effective way to gauge the role alcohol plays in your life, which may lead to lasting behavioral change. The 2019 study from the University of Sussex found that 81 percent of surveyed Dry January participants felt more in control of their drinking after the challenge.

While the challenge was designed to be complete abstinence from alcohol, you can adapt it to your lifestyle and needs. No one size fits all, Gans says. For context, half of the participants surveyed by Morning Consult plan to abstain from alcohol entirely, with the other half planning to reduce consumption. If youre considering taking on the challenge in any form, read on to see the benefits of Dry Januaryand perhaps be persuaded as to why it might be right for you.

This content is imported from {embed-name}. You may be able to find the same content in another format, or you may be able to find more information, at their web site.

Depending on an individuals specific drinking habits and starting weight, taking a monthlong break from alcohol could result in losing weight or generally feeling less bloated. Alcohol has liquid calories, which dont provide the same nutrients as the ones found in food. If people dont replace the weekly calories consumed from alcohol with other beverages or food, it will automatically create a deficit that will result in pounds lost, Gans says.

Research shows that alcohol influences our food choices. A study from the American Journal of Health Studies shows that food cravings are more intense and frequent when alcohol is consumed, and people are more likely to reach for characteristically unhealthy food to satisfy those cravings. Essentially, Gans says, drinking can influence people to be less controlled in their eating. Having alcohol out of your system for an extended period of time may lead to making more conscious food choices and developing healthier eating habits.

As you may already know, alcohol often has a sedative effect. It can help a person fall asleep more quickly, Gans says. But the quality of that sleep, Gans says, isnt optimal. Gans explains that the sedative effects of alcohol can wear off and actually lead to a more restless night. Additionally, Gans asks us to consider the effects of not staying up for one more beer. Less alcohol consumption could simply mean getting home earlier, and getting more sleep.

In addition to health benefits, Dry January often has a fiscal boon. Maybe youll spend less on the weekly grocery run. Or maybe youll skip out on those $15 cocktails. Either way: That money adds up. Your wallet will thank you.

Along with rethinking one dietary habit, Dry January offers a great opportunity to build another: Drinking more water. If youre someone who typically has a glass of wine or a beer with dinner, Gans recommends replacing that drink with a cool glass of H20. Water has countless documented benefits, from reducing bloating to getting smoother skin. Water is needed by every cell in our body to perform at its best, Gans says.

Dry January might be the secret ingredient your skincare cabinet was missing. Alcohol can have an effect on your overall appearanceespecially your skin. The biggest problem? Since its a diuretic, or a substance that rids your body of water, alcohol can result in dehydration, and in turn lead to a loss of skin elasticity and enlarged pores. Alcohol can also lead to skin inflammation, giving a red and puffy complexion. Essentially, by the end of the month, you may be looking dewier.

During Dry January, you may be replacing alcohol with energyheaps of it. The University of Sussex measured that 67 percent of Dry January participants had more energy than before. This may manifest in physical activity: Gans says you may have the wherewithal to work out in the morning or evening. Alcohol can lead to sleepiness, so cutting back may lead to alertness in the morning. You wont be drinking as much during Dry Januarybut imagine what else you can be doing.

This content is created and maintained by a third party, and imported onto this page to help users provide their email addresses. You may be able to find more information about this and similar content at piano.io

Go here to see the original:
What Is Dry January and What Are the Health Benefits? - Oprah Mag

Posted in Lose Weight Fast | Comments Off on What Is Dry January and What Are the Health Benefits? – Oprah Mag